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 Although the primary function of autophagy is the supply of amino 
acids as a response to starvation conditions in many organisms, recent studies 
suggested that basal autophagy, which occurs independently of nutrient 
stress, also plays an important role in maintaining cellular homeostasis, 
particularly in quiescent cells such as neurons. FIP200 (FAK family interacting 
protein of 200 KDa) was recently proposed as a mammalian counterpart of 
yeast Atg17 (autophagy-related 17) required for autophagosome initiation 
despite its different structure and sequence from Atg17. However, it remains 
unclear whether mammalian FIP200 regulates autophagy in vivo and the 
regulation is also involved in neuronal homeostasis and neurodegeneration. In 
this study, the results collected from the brain of which FIP200 was depleted 
by nestin-Cre showed that cerebellar degeneration and ataxia accompanied by 
progressive loss of Purkinje cells, swelling and degeneration of their axons, 
and spongiform degeneration in the cerebellum. Further analyses by 
conditional deletion of FIP200 using hGFAP-Cre and L7-Cre with 
complementary Cre expression in the cerebellum provided support for a 
Purkinje cell-autonomous function of FIP200 in the regulation of cerebellar 
degeneration. Consistent with a role of FIP200 in autophagy, observed 
progressive accumulation of abnormal ubiquitinated protein aggregates 
without any impairment of the ubiquitin-proteasome activity, increased 
apoptosis, and mitochondrial damage in Purkinje cells were found in the 
mutant mice. Lastly, the study demonstrated that deletion of TNF-R1 rescued 
both the loss of Purkinje cells and spongiform degeneration in FIP200 
conditional KO mice. Together, these results provided compelling genetic 
evidence that FIP200 regulation of autophagy and TNFR1 signaling 
playscritical roles in the pathogenesis of neurodegenerative disorders in 
mammals.
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CHAPTER 1
INTRODUCTION
1.1 FIP200
 FIP200 (FAK-family Interacting Protein of 200   kDa) was first 
characterized as a Pyk2 interacting protein through a yeast two-hybrid screen 
in our laboratory in 2000 (Ueda et al., 2000). Before our characterization, the 
full length cDNA for FIP200 (named as KIAA0203) was already isolated in 
projects of sequencing human cDNA clones (Nagase et al., 1996), but without 
any details or further describing of its possible functions. In the late-90’s, 
Maucuer found that fragments of FIP200 (designated as CC1) functions as a 
stathmin interacting protein (Maucuer et al., 1995).  Soon after Maucuer’s 
report, Fragments of FIP200 (named as LaXp180) were also found as a binding 
partner of the Listeria monocytogenes surface protein ActA in Pfeuffer’s study 
(Pfeuffer et al., 2000). In 2002, another independent identification for full 
length FIP200 reported it as a potential regulator of the RB1 gene (designated 
as RB1CC1 for RB1-inducible coiled-coil 1) (Chano et al., 2002b). Further 
studies have shown that FIP200 functions as a critical signaling molecule to 
regulate cell growth, cell proliferation, cell survival, and cell spreading/
migration. Furthermore, deletion of FIP200 has been shown to lead to 
embryonic lethality in mice (Gan et al., 2006).
1.1.1 FIP200 gene expression, protein structure and subcellular localization
 FIP200 is an evolutionarily conserved protein in human, mouse, 
rat,  Xenopus laevis,  Drosophila melanogaster  and  Caenorhabditis elegans. 
Although the function of FIP200 orthologues in other species remains 
unknown, studies have shown that FIP200 is widely expressed in various 
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human and mouse tissues, particularly abundant in heart, testis and 
musculoskeletal systems (Chano et al., 2002b; Chano et al., 2002d). More 
interestingly, FIP200 is copiously expressed throughout mouse embryonic 
development (Bamba et al., 2004), suggesting that FIP200 may play an 
important role in embryogenesis.
 The Mouse   FIP200   gene localizes in chromosome 1A2-4, which is 
syntenic to human chromosome 8q11. Both mouse and human FIP200 genes 
consist of 24 exons and share similar genomic structures. In addition, FIP200 
proteins in mouse and human share around 90% identity and similar domain 
structure (Chano et al., 2002b). FIP200 gene encodes a 200 kDa protein (1591 
aa) with several identifiable domains, such as a large coiled-coil region 
(residues 860–1391), a leucine zipper motif (residues 1371–1391), and a 
putative nuclear localization signal (NLS). (Figure 1.1) In summary, FIP200 has 
been mostly reported as a cytoplasmic protein (Gan et al., 2005; Gan et al., 
2006; Maucuer et al., 1995; Pfeuffer et al., 2000; Ueda et al., 2000) and 
conditionally localizes in focal adhesion (Abbi et al., 2002) as well as nucleus 
(Chano et al., 2002b; Melkoumian et al., 2005).
 The studies in first decade have identified 10 proteins as FIP200 
interacting proteins, including stathmin (Maucuer et al., 1995), Pyk2 (Ueda et 
al., 2000), FAK (Abbi et al., 2002), ActA (Pfeuffer et al., 2000), p53 (Melkoumian 
et al., 2005), TSC1 (Chano et al., 2006; Gan et al., 2005), ASK1, TRAF2 (Gan et 
al., 2006), ULK1 (Hara et al., 2008), and Atg13 (Ganley et al., 2009; Hosokawa 
et al., 2009; Jung et al., 2009). Because these interacting proteins regulate 
different cellular functions including microtubule dynamics, adhesion, 
migration, proliferation, growth, and stress response, the data suggest that 
FIP200 may play very diverse biochemical functions with different binding
2
3Figure 1.1 | Structural domains of FIP200.
FIP200 consists of a putative nuclear localization signal (NLS) at N-terminus, a 
large coiled-coil (CC) domain and a leucine zipper (LZ) motif located at C-
terminus.
partners to integrate various signaling pathways in cells (Figure 1.2).
1.1.2 FIP200 function in cell survival
 As mentioned earlier, FIP200 was initially identified as a Pyk2 
interacting protein (Ueda et al., 2000)  and their interaction was shown to 
inhibit   the kinase activity of Pyk2, which can suppress Pyk2-induced 
apoptosis (Avraham et al., 2000; Xiong and Parsons, 1997). Our study also 
showed that  activation of Pyk2 correlates with  dissociation of endogenous 
FIP200–Pyk2 interaction under several biological stimuli. Taken collectively, 
it   indicates that FIP200 functions to promote cell survival through its 
inhibition of Pyk2 activity.
 Importantly, the pro-survival function of FIP200 was further 
investigated in recent FIP200 knockout (KO) mice study. The study has shown 
that homozygous deletion of FIP200 in mouse leads to embryonic lethality 
associated with massive apoptosis in liver and heart (Gan et al., 2006).  To 
further understand the mechanism of regulation of apoptosis by 
FIP200,  FIP200 KO MEFs and fetal liver cells have been isolated; however, 
these cells  do not show increased apoptosis either under normal or various 
apoptosis-induced culture conditions, such as energy deprivation or sorbitol 
treatment. Interestingly,   FIP200 KO MEFs and fetal liver cells show an 
elevated sensitivity to TNFα-induced apoptosis. It has been known that TNFα 
activates JNK through TNFR–TRAF2–ASK1–MKK4/MKK7–JNK signaling 
cascade (Davis, 2000; Lee et al., 1997; Nishitoh et al., 1998; Tobiume et al., 
2001). Our further studies show that FIP200 associates with ASK1 and TRAF2, 
functions as a scaffold protein to orchestrate TRAF2–ASK1 signaling. The 
protein complexes are capable of increasing JNK serine/threonine-
4
5Figure 1.2 | FIP200 signaling pathway.
FIP200 functions to regulate diverse cellular processes, including cell 
proliferation, cell spreading, cell migration, cell growth, cell survival and 
protein quality control. FIP200 suppresses cell proliferation by regulation of 
p53–p21, cyclin D1, Rb1 and FAK pathways; FIP200 negatively regulates cell 
spreading and migration by its inhibition of FAK function; FIP200 promotes 
mTOR activation and cell growth through its interaction with TSC1–TSC2 
complex; FIP200 positively regulates cell survival by its inhibition of Pyk2 
activity and regulation of TNFα–JNK signaling cascade; FIP200 initiates basal 
autophagosome formation to remove aberrant protein aggregation by forming 
a protein complex with ULK1 and Atg13.
phosphorylation upon  TNFα stimulation (Gan et al., 2006).  Because  NF-κB 
signaling and Pyk2 activation remain unaffected in FIP200 KO MEFs and liver 
cells, the defective JNK pathway is subsequently identified to be responsible 
for increased TNFα-stimulated apoptosis (Gan et al., 2006).   In summary, 
FIP200 promotes cell survival through at least two different mechanisms. One 
is through inhibition of Pyk2 activity; the other is through   TNFα-JNK-
dependent mechanism.
1.1.3 FIP200 function in cell proliferation
 Our lab initially showed that over-expression of FIP200 inhibits cell 
proliferation in NIH3T3 cells and the inhibition of cell proliferation could be 
reversed by co-expression of FAK. Furthermore, we found that the disruption 
of the interaction between endogenous FIP200 and FAK leads to enhanced 
tyrosine phosphorylation of FAK and partial restoration of cell cycle 
progression of cells plated on poly-L-lysine (Abbi et al., 2002). These results 
suggest that FIP200-mediated inhibition of cell proliferation is at least partly 
through its inhibition of FAK signaling. Another study from our lab 
documents that over-expression of FIP200 can also inhibit cell proliferation 
and induce cell cycle G1 phase arrest in human breast cancer cells 
(Melkoumian et al., 2005) through an increase of p21 and a decrease of cyclin 
D1 protein levels. The upregulated p21 expression is because of stabilized p53 
in nucleus by the interaction of FIP200 with p53. In contrast to p21, the 
decrease of cyclin D1 protein by FIP200 is facilitated by an increased 
proteasome-dependent degradation of cyclin D1. Interestingly, it is found that 
FIP200-induced G1 arrest is independent of FAK pathway in the breast cancer 
cells studied (Melkoumian et al., 2005). In other words, FIP200 can regulate 
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cell proliferation through FAK dependent and independent mechanisms. 
 Many studies have suggested that expression or tyrosine-
phosphorylation levels of FAK correlate with cancer development (Agochiya 
et al., 1999; Jones et al., 2000; Owens et al., 1995). Conditional deletion of FAK 
in mice suppresses chemically induces skin tumor formation and blocks 
malignant progression (McLean et al., 2004), providing the direct evidence 
implicating the critical role of FAK in tumorigenesis. These studies, therefore, 
raise an interesting possibility that FIP200 might potentially function as a 
tumor suppressor through the inhibition of FAK activity and cell proliferation. 
Besides, over-expression of FIP200 has been shown to inhibit cell proliferation 
resulting from upregulated expression of RB1 in human leukemic cells, such 
as K562 and Jurkat cells (Kontani et al., 2003). RB1 expression correlates with 
truncated FIP200 expression in the breast cancer cells. These data suggest that 
FIP200 regulation of RB1 expression might play a role in its tumor suppression 
(Chano et al., 2002c).
 Therefore, these studies provide strong evidence that FIP200 functions as 
a negative regulator in cell cycle progression through different downstream 
signaling pathways in different cellular contexts.
1.1.4 FIP200 function in protein synthesis and cell growth
 Cell growth (increase in cell mass and size) is an orchestrated cellular 
process, which must be tightly regulated by both intracellular and 
extracellular stimuli.  The studies from the last decade have identified the 
mammalian target of rapamycin (mTOR) as a critical regulator of cell growth 
through its regulation of a variety of cellular functions, including initiation of 
mRNA translation, ribosome synthesis, expression of metabolism-related 
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genes and autophagy (Schmelzle and Hall, 2000). The mTOR activity can be 
up-regulated by the small GTPase Rheb (Ras homolog enriched in brain) or 
down-regulated by   TSC1/2 complex, which   stimulates Rheb GTP 
hydrolysis.  Therefore,  phosphorylation levels of ribosomal S6 kinase (S6K) 
and eukaryotic initiation factor 4E binding protein-1 (4EBP-1) (Wullschleger et 
al., 2006), two key downstream targets of mTOR,  are regulated by growth 
factors and nutrient stimuli. 
 Recently, FIP200 was identified as a TSC1 interacting protein through 
yeast two-hybrid screens (Gan et al., 2005).   Our study showed that the 
interaction of FIP200 and TSC1 correlates with  mTOR activation and cell 
growth.   Over-Expression of FIP200 up-regulates mTOR activation and 
increases cell size whereas RNAi knockdown of endogenous FIP200 
suppresses mTOR activation and reduces cell size (Gan et al., 2005). FIP200 
also has been shown to inhibit TSC1-TSC2 complex by promoting TSC1 
degradation through the ubiquitin proteasome pathway (Chano et al., 
2006). Taken collectively, the results suggest that FIP200 inhibits TSC function 
through disruption of TSC1–TSC2 complex formation, therefore 
increasing activity of mTOR. 
 Moreover, over-expression of FIP200 can promote mTOR activation and 
cell growth under nutrient deprived conditions. It has also been documented 
that FIP200 is important in nutrient stimulation-induced, but not energy- or 
serum-induced, mTOR activation (Gan et al., 2005).   Interestingly, FIP200 is 
independently identified as the regulator of TSC-mTOR signaling by a 
different approach as well (Chano et al., 2006). These studies show that RNAi 
knockdown of FIP200 in mouse muscle cells reduces cell size, suggesting that 
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FIP200 may play a role in the regulation of muscle hypertrophy/atrophy in 
vivo (Chano et al., 2006).
 In summary, FIP200 functions as a promoter in protein synthesis and cell 
growth by inhibiting the function of   tumor suppressor TSC1 and TSC2, 
activating mTOR signaling.
1.1.5 FIP200 function in autophagy
 Recently FIP200 has been identified as a novel ULK1-interacting 
protein. The interaction of FIP200 and ULK1 is via the C-terminal region of 
ULK1 (Hara et al., 2008). In addition, FIP200 is identified as a substrate of 
ULKs. The phosphorylation of FIP200 by ULK1 can be detected in 293T lysates 
over-expressing FIP200 and ULK1 (Ganley et al., 2009) and at autophagosomal 
structures under mTOR inactivation (Hara et al., 2008). Because FIP200 KO 
MEFs have no detectable autophagosome (Hara et al., 2008), the results 
suggest that the interaction of FIP200 and ULK1 plays a role in an early step of 
autophagosome formation. Recent studies have shown that FIP200 is a part of 
the ULK1-Atg13-FIP200 protein complex (Ganley et al., 2009; Hosokawa et al., 
2009; Jung et al., 2009) and the complex is prior to autophagy induction 
(Ganley et al., 2009). Interestingly, aside from its interaction with Atg13 (Chan 
et al., 2009) and FIP200 (Hara et al., 2008), ULK1 can also bind to SynGAP and 
syntennin to regulating the neuronal axon outgrowth (Chan et al., 2007; 
Tomoda et al., 2004). The results suggest that FIP200 may have important 
functions in neurons.
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1.1.6 FIP200 function in cell spreading and migration
 FIP200 has been shown to colocalize with FAK at focal adhesions 
through its association with FAK kinase domain. The interaction between 
FIP200 and FAK inhibits FAK kinase activity, autophosphorylation of 
tyrosine-397, and cellular functions in cell spreading and migration (Abbi et 
al., 2002). The endogenous interaction between FIP200 and FAK is detected in 
suspended cells but decreased upon cell attachment on fibronectin (FN) (Abbi 
et al., 2002), suggesting that integrin signaling negatively regulates this 
interaction to activate FAK and its downstream pathways. Additionally, co-
expression of FAK can reverse the inhibition of cell spreading and migration 
by FIP200, suggesting that FIP200 regulation of cell spreading and migration is 
through its inhibition of FAK signaling.
 Cell spreading and migration play essential roles in numerous 
biological processes such as embryogenesis, angiogenesis, wound repair, 
inflammatory immune response, and cancer metastasis (Christopher and 
Guan, 2000; Lauffenburger and Horwitz, 1996). Studies have reported that 
FAK functions as a crucial molecule in integrin-mediated cell spreading and 
migration (Abbi and Guan, 2002; Mitra et al., 2005). Other studies have also 
identified several protein tyrosine phosphatases, such as PTEN, as a FAK 
inhibitor by tyrosine-dephosphorylation of FAK (Tamura et al., 1998; Yu et al., 
1998). In contrast, FIP200 binds to the FAK kinase domain to inhibite FAK 
kinase activity, representing an alternative regulatory mechanism of FAK 
function. Since FAK activity has been implicated in cancer metastasis (Mitra 
and Schlaepfer, 2006), generation of small peptides or their derivatives from 
FIP200 as inhibitors for FAK could be of potential therapeutic significance.
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1.1.7 FIP200 function in cell differentiation
 The potential role of FIP200 in cell differentiation is first implicated by 
its increasing expression during the maturation process of musculoskeletal 
cells (Chano et al., 2002a). Another example, upon myoblast differentiation 
FIP200 gene expression is induced in C2C12 cells, it correlates with the 
upregulation of Rb1 and myoblast differentiation marker proteins Myhc 
(Watanabe et al., 2005). The C2C12 myoblast differentiation process can be 
suppressed by RNAi knockdown of endogenous FIP200 (Watanabe et al., 
2005). Together, these data identify that FIP200 as a potential regulator of 
myogenic differentiation.
1.1.8 The role of FIP200 in embryonic development
 FIP200 is copiously expressed throughout mouse embryonic 
development (Bamba et al., 2004). The expression pattern suggests that FIP200 
may play an important role in embryogenesis. Our study has shown that 
targeted ablation of FIP200 in mice leads to embryonic lethality at mid/late 
gestation associated with heart failure and liver degeneration (Gan et al., 
2006).   FIP200 KO embryos at E14.5 and E15.5 lose much of the normal 
trabecular and external compact myocytes, resulting in significantly thinner 
heart ventricular walls with fewer cells. Besides, the majority of the FIP200 KO 
embryos also show severe liver degeneration characterized by loosely 
arranged hepatocytes mixed with numerous red blood cells. Hepatocytes are 
isolated from each other because of hemorrhage in the liver. Our study further 
identifies that the heart failure and liver degeneration found in FIP200 KO 
embryos results from massively increased apoptosis (Gan et al., 2006).
 FIP200 has been shown to regulate cell size through its interaction with 
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TSC1–TSC2 complex. Interestingly, TSC1 and TSC2 KO embryos present 
severe heart defects with thickened ventricular walls (Kobayashi et al., 1999; 
Kobayashi et al., 2001). The opposite defective cardiac phenotypes suggest that 
FIP200 might function as the antagonist for TSC1-TSC2 complex. In addition, 
the isolated cardiomyocytes from FIP200 KO embryos show decreased mTOR 
activation and reduced cell size (Gan et al., 2006). Taken together, the in vivo 
results indicate that FIP200 play an important role in cell size/cell growth 
during heart development.
 The liver degeneration phenotype found in FIP200 KO embryos is similar 
to the KO embryo phenotypes of several deletions of components of TNFα 
signal pathways, including Rel A, IKK-β, IKK-γ, GSK-3, MKK4, MKK7, or c-
Jun. These embryos are characterized by mid/late gestational lethality 
associated with increased apoptosis in liver as well (Beg et al., 1995; Hilberg et 
al., 1993; Hoeflich et al., 2000; Li et al., 1999; Nishina et al., 1999; Rudolph et al., 
2000; Wada et al., 2004).  Furthermore, FIP200 KO MEFs exhibit increased 
apoptosis upon TNFα treatment because of reduction of JNK phosphorylation. 
Additionally, analysis shows that the interaction of FIP200 with TRAF2 and 
ASK1 is responsible for regulating ASK1 and JNK phosphorylation  for cell 
survival (Gan et al., 2006).
1.1.9 The role of FIP200 in psoriasis
 Using a conditional KO approach, ablation of FIP200 in skin causes skin 
inflammatory diseases resembling aspects of human psoriasis (Wei et al., 
2009). The mutant mice showed activation of   NF-κB and up-regulation 
of proinflammatory cytokines, including TNFα, IL-1β, IL-6, and IFNγ in the 
skin environment. These proinfnflammatory cytokines are also seen in lesions 
12
of human psoriasis. Although previous studies suggest that inactivation of 
FIP200 does not affect NF-κB signaling in MEFs (Gan et al., 2006), ablation of 
FIP200 in keratinocytes could interfere with the balance of NF-κB activity to 
trigger an inflammatory response.
1.1.10 The potential Role of FIP200 in Alzheimer’s disease (AD)
 FIP200 is copiously expressed in both developing and mature neuronal 
cells. A recent study suggests that FIP200 may play a role in the regulation of 
neuronal size through its regulation of TSC1 degradation, mTOR, and RB1 
(Chano et al., 2006). Analysis of samples from AD patients showed that 31% of 
the samples exhibited a decrease in FIP200 expression and phosphorylation of 
S6. These   studies also demonstrate that specific knockdown of FIP200 in 
Neuro-2a cells induces the inhibition of the mTOR signaling pathway, 
resulting in neurite atrophy and cell death. Thus, these observations suggest 
that insufficiency or dysfunction of FIP200 may be involved in the 
pathogenesis of AD or contributes to the pathogenesis of neurodegenerative 
brains like AD (Chano et al., 2007).
1.2 Cerebellum
 Despite its small portion to total volume of the brain in mice, the 
cerebellum contains more than half of all the neurons in the central nervous 
system (CNS) (Kandel et al., 2000).  These neurons are arranged in a highly 
regular order of cellular organization resulting from repetition of the same 
neural circuit module. The structural regularity of the cerebellum suggests 
that all neural circuit modules execute similar functions. Interestingly, the 
cerebellum can be further dissected into several distinct regions. Each region 
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of the cerebellum functions on a distinct set of inputs and connects with 
different areas of the brain. Thus, the cerebellum indirectly mediates 
movement and posture by modifying the output of the major descending 
motor systems in CNS (Ito, 1984). Different from the lesions of the motor 
cortex, which reduce the movement strength and speed resulting from losing 
the capability of individual muscles to contract, damages occurred in the 
cerebellum distort movement coordination of limb and eye, cause an 
impairment of balance, and decrease muscle tone.
1.2.1 The developmental organization of the cerebellum
 The spatial organization of the cerebellum is crucial for its proper 
functioning. Such a structure is the result of the subtle modification from the 
differential neuronal proliferation, selective cell death, and cell migration 
during development. The mouse cerebellum reaches its final configuration 
over a 6-week period between embryonic age E7 and postnatal age P30. The 
origin of all cerebellar neuronal precursors is a germinal matrix consisting of 
the ventricular neuroepithelium and the rhombic lip (Goldowitz and Hamre, 
1998). 
 The interneurons in the cerebellar cortex arise from the metencephalon 
and the mesencephalon (Manto and Pandolfo, 2002). The ventricular 
neuroepithelium produce cerebellar nuclear neuroblasts, Purkinje neuroblasts, 
and Golgi neuroblasts (Goldowitz and Hamre, 1998; Wang and Zoghbi, 2001). 
The generation of cerebellar nuclear neuroblasts from the ventricular 
epithelium is further characterized as the first migration stage of primitive 
cells.  Initial cluster of Purkinje neuroblasts moves outward radially during the 
second migration stage. Granule cell neuroblasts, basket cell neuroblasts and 
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stellate cell neuroblasts migrate away from germinal neuroephithelium to the 
outer surface of the developing cerebellum, forming the external granule layer. 
The outer boundary of the external granule layer is composed of proliferating 
neuroblasts but the inner compartment contains post-mitotic precursors of 
granule neurons. Interestingly, the size of the population of granule neurons is 
determined by the number of Purkinje cells during the development of the 
cerebellum. This is that the Purkinje cell secretes Sonic hedgehog to sustain the 
mitotic activity of granule neuron precursors within the external granule layer 
(Wallace, 1999). Then, these post-mitotic granule neurons migrate into the 
developing cerebellar white matter to generate the internal granule layer, 
which is characterized as the third migration stage. During this final migration 
stage, the neural-glial interaction between granule cell precursors and 
Bergmann glia is important for positioning granule neurons. The granule cell 
precursors migrate via the long processes of the Bergmann glia (Rakic and 
Sidman, 1973) till reaching their destination. During the third migration stage, 
the external granular layer will disappear progressively (Altman, 1972a; 
Altman, 1972b; Rakic, 1971).
1.2.2 The composition of cerebellum
 The cerebellum has a unique structure to wrap up an enormous 
number of interconnected elements into a small volume (Figure 1.3). It is 
composed of the cerebellar cortex and a set of cerebellar nuclei. The 
morphological unit of the cerebellum is a folium, which contains afferents and 
efferents in the middle and the cerebellar cortex on both sides. Interestingly, 
the cerebellar cortex contains more neurons and synapses than the rest of the 
brain. The cerebellar cortex is a simple but highly regular structure which only
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Figure 1.3 | Basic structure of the cerebellar cortex.
There are two main afferents to the cerebellar cortex: climbing fibres, which 
make direct excitatory contact with the Purkinje cells, and mossy fibres, which 
terminate in the granular layer and make excitatory synaptic contacts mainly 
with granule cells, but also with Golgi cells. In some cases, the stem axons of 
climbing and mossy fibres also provide collaterals to the cerebellar nuclei en 
route to the cerebellar cortex. The ascending axons of the granule cells branch 
in a T-shaped manner to form the parallel fibres, which, in turn, make 
excitatory synaptic contacts with Purkinje cells and molecular layer 
interneurons — that is, stellate cells and basket cells. Typically, parallel fibres 
extend for several millimetres along the length of individual cerebellar folia. 
With the exception of granule cells, all cerebellar cortical neurons, including 
the Purkinje cells, make inhibitory synaptic connections with their target 
neurons †From (Apps and Garwicz, 2005), courtesy of the author.
consists of three distinct layers-molecular layer, Purkinje cell layer, and 
granule layer (Kandel et al., 2000)-as well as eight types of neurons-basket 
cells, stellate cells, Purkinje cells, Lugaro cells , Golgi cells, granule cells, 
unipolar brush cells and candelabrum cells (Laine and Axelrad, 1994; 
Mugnaini and Floris, 1994).
1.2.2.1 Granule Cells
 The innermost granular layer contains a huge number of tightly packed 
small granule cells as well as two inhibitory interneurons, Lugaro cells and 
Golgi cells. Granule cells are round or oval shape, with a diameter of 5-8 μm, 
and are the main component of the granular layer. In humans, the 
number between 1010 and 1011, with about 3 to 7 million cells/mm3, has been 
estimated as the total amount of granule cells. Each granule cell has thinness 
of the rimming cytoplasm and presents about  4 to 5 dendrites, forming 
excitatory synaptic contacts with the mossy fiber branches at  the cerebellar 
glomeruli. The granule dendrites also construct inhibitory synapses with 
axons of Golgi cells. The axon of the granule cells is unmyelinated and extends 
up perpendicularly to the molecular layer, where it forms T-shaped branches 
running parallel to the axis of the folium in opposite directions. These parallel 
fibers form excitatory synapses with the spines of the Purkinje cell dendritic 
arbor. Approximately, one Purkinje dendritic tree has 4,000,000 parallel fibers 
cross through and about 80,000 parallel fibers form a single synapse with the 
same number spines of one Purkinje cell. Primarily, these parallel fibers consist 
of the outermost molecular layer. Aside from parallel fibers, the molecular 
layer also contains the dendrites of the underlying Purkinje neurons as well as 
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scattered two types of inhibitory interneurons, stellate and basket cells, which 
are responsible for balancing the excitation on the Purkinje cells. 
1.2.2.2 Inhibitory Interneurons
 Basket cells are only found in mammals and birds (Llinás and American 
Medical Association Education and Research Foundation. Institute for 
Biomedical Research., 1969), with a ratio of one per six Purkinje cells. One 
basket cell functions as an inhibitory interneuron to about eight to nine 
Purkinje cells. Its dendritic tree expanses to the pial surface and make 
synapses with the parallel fibers as well. The axon of basket cell runs above 
the row of Purkinje cells and perpendicularly to the axis of the folium. Stellate 
cells, the other inhibitory interneuron in the molecular layer, are located in the 
outer two-thirds of the molecular layer. Their dendrites form inhibitory 
synapses with the Purkinje cell dendrites.   In addition, basket cells, stellate 
cells, and Purkinje cells all share the same parallel fiber input. Aside from 
basket and stellate cells, as mentioned earlier, Lugaro and Golgi cells are 
inhibitory interneurons in the granular layer. Lugaro cells locate just under the 
Purkinje cells. Their dendrites receive massive innervation from Purkinje cell 
axon collaterals and their axons reach out into the molecular layer where 
Lugaro cells form plenty of symmetrical gamma-aminobutyric acid-
(GABA)ergic synapses with basket and stellate cells (Laine and Axelrad, 1998). 
Golgi cells, more interestingly, are negatively regulated by Purkinje cell 
collaterals but inhibit the synaptic transmission between mossy fiber rosettes 
and granule cell dendrites. Because the dendritic arbor of Golgi cells also 
receives excitatory synaptic input from the parallel fibers, from the 
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connections, the gate of mossy fiber input is tightly controlled by Purkinje 
cells.
1.2.2.3 Purkinje cells
 Underneath the molecular layer is the Purkinje cell layer, which is 
composed of a single layer of Purkinje neurons, separating the outer molecular 
layer from the inner granular layer.  The Purkinje neurons have large cell 
bodies (50~80 μm) and their extensive dendritic trees perpendicular to the axis 
of a folium reach out into the molecular layer. All Purkinje neurons are 
characterized as inhibitory GABAergic (Ito and Yoshida, 1964) projection 
neurons and they are the sole output of the cerebellar cortex. One given 
Purkinje cell may form as many as 100,000 synapses with other neurons, 
which is more than any other neuron studied. Their axons leave the lower 
rounded pole, widen, and become myelinated. In the granular layer, these 
axons discharge many collaterals oriented perpendicularly to the folium 
axis. They further extend down into the underlying white matter where they 
target the deep nuclei and vestibular nuclei. A typical Purkinje cell gives off 
500 terminals to contact 35 cerebellar nuclei.
1.2.2.4 Deep cerebellar nuclei
 The cerebellar nuclei are the target of the Purkinje cell axons, with an 
average ratio of one per 26 Purkinje cells. A nuclear cell receives a dense 
Purkinje cell innervation, of which about 14 inhibitory terminals are from the 
same Purkinje cell and 12,000 terminals from 860 different Purkinje cells. It has 
been shown that glutamate is the neuromediator (Schwarz and Schmitz, 1997) 
and the excitatory input for the cerebellar nuclei from collaterals of the 
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climbing and mossy fibers. However, the mossy fibers are the major excitatory 
input to the nuclear cells. Interestingly, in some cases, the cerebellar nuclei 
project to vermis where the Purkinje cells do not make projections back to the 
dentate nucleus. It suggests that these connections may be presented either as 
a negative feedback or as an open communication between different areas of 
cerebellum.
1.2.2.5 Mossy fibers and climbing fibers
 Mossy fibers are characterized as the major glutamatergic and excitatory 
inputs to the cerebellum. The sources of mossy fibers include the cortex, the 
vestibular nerves and nuclei, the spinal cord (Matsushita et al., 1979), the 
reticular formation, and feedback from cerebellar nuclei (Gould, 1979; Tolbert 
et al., 1978). Different axons ascend into the white matter of the cerebellum 
where they contact with deep cerebellar nuclei as well as innervate granule 
cells at the cerebellar glomeruli. Therefore, the mossy fibers are able to pass 
the sensory information to the granule cells, which then send it along the 
parallel fibers to the Purkinje cells for processing. 
 The other excitatory input to the cerebellum is climbing fibers. The 
sources of climbing fibers are axons from the  inferior olivary nucleus located 
in the medulla (Desclin, 1974; Sotelo et al., 1975). The axons enter the 
cerebellum and make synapses with the deep cerebellar nuclei and Purkinje 
cells. A recent study has shown that climbing fibers play an important role in 
motor behaviors (McKay et al., 2007).
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1.3 Purkinje Cell
1.3.1 Purkinje cell development
 Purkinje cell neuroblasts of the cerebellum arise from the anterior 
metencephalon. Between E10 and E13, the Purkinje cell precursors undergo 
their final mitosis in the subventricular germinal zone (Miale and Sidman, 
1961) and then commit to become Purkinje cells (Leclerc et al., 1988; Oberdick 
et al., 1993; Seil et al., 1995; Wassef et al., 1990). The post-mitotic Purkinje cells 
migrate into the anlage of the cerebellum via radial glial guidance (Edwards et 
al., 1990). Initially, they aggregate together and form a layer with 10–15 cells 
thick. The undeveloped Purkinje cell layer further divides into clusters 
(Armstrong and Hawkes, 2000; Hawkes and Eisenman, 1997; Herrup and 
Kuemerle, 1997). After E14, these Purkinje cell clusters make contacts with 
newly entered mossy and climbing fibers (Arsenio Nunes and Sotelo, 1985; 
Chedotal et al., 1997; Grishkat and Eisenman, 1995; Ji and Hawkes, 1995). 
Consequently, clusters of Purkinje cells scatter to form a monolayer at around 
birth. Studies have shown that the Reelin-Dab1 pathway (Gallagher et al., 
1998; Howell et al., 1997; Sheldon et al., 1997), cadherins (Gilmore and Herrup, 
2000), and integrins (Dulabon et al., 2000) are involved in the scattering 
process of Purkinje cells. Finally, most Purkinje cells express calbindin 
uniformly in the postnatal period and develop elaborate dendritic arbors as 
well as synapses with granule cells during the first four postnatal weeks.
1.3.2 Activity regulation of Purkinje cells
 The Purkinje cells are the exclusive output of the cerebellar cortex and 
their activity is delicately regulated by two distinct excitatory fiber systems 
and three different local inhibitory interneurons in the cerebellum. Both fiber 
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systems, mossy fibers and climbing fibers, carry information flowing from the 
cerebral cortex or medulla into the cerebellum and initially influence on the 
deep cerebellar nuclei. Their collateral axon branches make contacts with the 
deep cerebellar nuclei, which form the primary cerebellar circuit. Interestingly, 
mossy fibers and climbing fibers inputs are each regulated distinguishably in 
response to sensory stimulation and motor actions. Mossy fibers excite 
Purkinje cells indirectly through local clusters of granule cells in cerebellar 
glomeruli. First, the mossy fibers activate the granule cells and then the 
granule cell axons, the parallel fibers, make robust excitatory connections with 
nearby Purkinje cells. Each Purkinje cell receives input from nearly 200,000 
parallel fibers, which collect excitatory input from many mossy fibers. Similar 
to the mossy fibers, the synapses of climbing fibers are all excitatory. The 
climbing fibers can transiently enhance the influence of mossy fiber inputs on 
Purkinje cells as well as induce large excitatory postsynaptic potentials in both 
the soma and dendrites of the Purkinje cells. Despite the primary circuit 
initially activating Purkinje cells, the initial excitation is further modulated by 
the inhibitory action of the Purkinje neurons.
 The activity of the Purkinje cells is also regulated by local inhibitory 
interneurons- basket, stellate, and Golgi cells - which all receive excitatory 
inputs from the parallel fibers but function in different ways. The axons of 
basket cells make contact with the cell bodies of more distant Purkinje cells. As 
a result, the excited basket cells inhibit the Purkinje cells outside where the 
excitation occurs. In contrast to basket cells, suppression from stellate cells is 
via their short axons contacting nearby dendrites of  Purkinje cells. More 
indirectly, Golgi cells inhibit Purkinje cells through the parallel fibers by 
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reducing the duration of excitation on granule cells within the cerebellar 
glomeruli.
1.3.3 Death of Purkinje cell
 Dysfunctional Purkinje cells in mice are often linked to several 
characteristic clinical symptoms, such as abnormal postures, gait 
abnormalities, tremor, and ataxia. Death of Purkinje cells is also exhibited in 
an atrophic cerebellum. If the Purkinje cell death occurs during the neonatal 
stage, the loss of cell bodies in Purkinje cell clusters results in the Purkinje cell 
layer containing fewer gaps in the adult cerebellum. In addition, the early 
death of Purkinje cells in development typically causes a reduced volume of 
cerebellum and severe morphological abnormalities (Millonig et al., 2000). In 
contrast, when the death of Purkinje cells happens in the adult cerebellum, it 
presents gaps both in the Purkinje cell layer and the molecular layer.
 Detection of whether the Purkinje cell undergoes naturally-occurring cell 
death during development remains unclear. There is no Purkinje cell death 
from P4 to adulthood (Caddy and Biscoe, 1979). Double positive staining of 
CaBP and TUNEL or active caspase-3 antibody of Purkinje cells in P3-P4 
cerebellum (Kitao et al., 2004; Marin-Teva et al., 2004) suggests that Purkinje 
cells engage in programmed cell death at P3-P4. However, it has been shown 
that caspase-3 mRNA is expressed at high levels in the Purkinje cell layer from 
P1 to P8 (de Bilbao et al., 1999). Active caspase-3 is present at all stages of 
Purkinje cell dendritic remodeling during the first 6 postnatal days 
(Madalosso et al., 2005). In addition, the developing Purkinje cells intensely 
express the pro-survival factor bcl-x mRNA in the developing cerebellum 
(Frankowski et al., 1995). The evidence obtained from transgenic mice has 
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shown that over-expressing Bcl-2 or inactivating Bax increases the number of 
Purkinje cells in young adult mice in the cerebella (27–40% for Bcl-2 transgenic 
mice (Zanjani et al., 1996) and approximately 30% for the Bax-/- (Fan et al., 
2001). However, in older Bcl-2 transgenic mice, the numbers of Purkinje cells 
in the cerebella are reduced at 6-months of age and then ultimately reach the 
control level by 18-months of age. The reduction in cell number correlates with 
the expression pattern of the exogenous human Bcl-2. It indicates that 
sustained expression of Bcl-2 is responsible for Purkinje cells survival (Zanjani 
et al., 2004).
 A study has shown that autophagy function as an anti-apoptotic 
clearance mechanism by discarding altered mitochondria (Brunk and Terman, 
2002). In addition, deficiency of autophagy leads to loss of the Purkinje cells 
(Hara et al., 2006; Komatsu et al., 2006). Autophagy, however, has been also 
proposed to be involved in neuronal cell death (Chang et al., 2003; Lang-Rollin 
et al., 2003; Xue et al., 1999). Inactivation of some atg components arrests 
neuronal cell death (Yuan et al., 2003). Therefore, whether the autophagy is 
responsible for the neuronal cell death remains controversial.
 It has been widely documented that the death of Purkinje cells often 
occurs along degenerative changes during aging. In older animals, the 
numbers of Purkinje cells have been shown to be decreased (Amenta et al., 
1994; Sturrock, 1989) and as many as 14% of Purkinje cells exhibit axonal 
spheroids or torpedoes (Baurle and Grusser-Cornehls, 1994). Moreover, 
degenerative Purkinje cells show the decreased activity of succinic 
dehydrogenase within mitochondria (Fattoretti et al., 1998), implying that 
degenerative changes during aging may be related to oxidative stress 
(Bickford et al., 2000). Besides, studies have shown that there are multiple 
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defects contributing to Purkinje cell loss as a secondary effect. These defects 
include the neurodegeneration of inferior olivary neurons (Ghetti et al., 1987; 
Shojaeian et al., 1988; Triarhou and Ghetti, 1991) or deep cerebellar nuclei 
(Triarhou et al., 1987; Wassef et al., 1986), and a significant loss of granule cells.
1.4 Protein quality control systems and neurodegeneration
 Proteins require proper folding to be fully functional after they are 
synthesized. To secure the integrity of cellular functions, the protein quality 
control systems play an essential role among various regulation machineries 
in a cell. Misfolded proteins are often non-functional and, sometimes, they 
form aggregates which may be toxic to the cells. Because protein misfolding 
can happen at different locations and anytime in the cell, protein quality 
control systems have evolved into complex mechanisms, including 
recognition of aberrant proteins, deposition of misfolded proteins in inclusion 
bodies, and degradation of targeting proteins, to protect cells from 
accumulation of misfolded proteins. However, the protein quality control 
systems may be impaired owed to aging or mutations. The deficiency in 
protein quality control systems could further increase the presence of end-
stage protein aggregates. Although it is still under debate whether the 
accumulation of protein inclusions is neurotoxicity or neuroprotection, most 
neurodegenerative diseases have been characterized by deposits of protein 
aggregates. Neurodegenerative disorders often produce and accumulate 
abnormal proteins within cells. The progressive intracellular accumulation of 
aberrant proteins may be resulting from the imbalance between the capability 
or activity of these quality control systems and the misfolded proteins. The 
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protein aggregates may further induce damages on cellular functions and 
eventually lead to cell death.
1.4.1 Ubiquitin-proteasome system (UPS)
 The ubiquitin-proteasome system (UPS) is known as the primary 
cellular protein degradation system (Figure 1.4). Most proteins tagged with 
polyubiquitin chains are destined for degradation by the proteasome. The 
ubiquitination involves a cascade of enzymes (Gao and Karin, 2005). The 
activation of ubiquitin by the enzyme E1 is the initial step of the process. The 
enzyme E1 forms a thiol-ester bond between its cysteine and the final glycine 
of ubiquitin and then transfers the ubiquitin to enzyme E2 via a trans-thio-
esterification reaction. The final step of ubiquitination requires the activity of a 
specific  enzyme E3 which creates an isopeptide bond between the C-terminal 
glycine of ubiquitin and a lysine of the target protein. Interestingly, 
ubiquitination has a  hierarchical organization. There are about ten E1s, about 
hundreds E2s and possibly thousands of E3s in humans (Hicke et al., 2005). 
More important, different E2/E3 combinations lead to the linkage-specific 
ubiquitin chains, such as K48 and K63 linkages. Of which, K48 linkages are the 
main peptide signal for degradation by the proteasome. Studies have revealed 
several proteins, such as RAD23, DSK2 and CDC48, that  are  responsible for 
transfering the polyubiqutinated proteins to the proteasome (Elsasser and 
Finley, 2005; Richly et al., 2005). The proteasome consists of a 20S catalytic core 
and a 19S lid. In the 19S lid, the S5a subunit initiates proteolysis by binding to 
polyubiquitinated proteins. The polyubiquitin chains are further cleaved by 
deubiquitinating enzymes. In addition, the target protein is unfolded and 
degraded by the three enzymatic activities: trypsin-like, chymotrypsin-like,
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Figure 1.4 | Schematic representation of the ubiquitin–proteasome system. 
The proteasome consists of a catalytic core and two regulatory caps. The core 
resembles a barrel–like structure consisting of four stacked rings that are made 
up of two types of subunits. One of the subunits is the site of the proteinase 
activities responsible for protein degradation. The two caps recognize and 
bind to proteins that are destined for degradation and help these proteins 
enter the channel in the center of the catalytic core. There, the proteins are cut 
into peptides that then can be degraded further into amino acids. Proteins to 
be degraded by the proteasome first must be marked by the addition of at 
least four ubiquitin molecules (Ub). Transfer of ubiquitin to the target proteins 
is mediated by ubiquitin–activating enzymes (E1), conjugating enzymes (E2), 
and ligating enzymes (E3). This process requires energy, which is provided by 
the form of adenosine triphosphate (ATP), the cell’s primary energy source. 
†From (Donohue, 2002), courtesy of the author.
and PGPH-like in the 20S catalytic core of proteasome (Pickart and Cohen, 
2004). Studies have shown that the UPS system plays an essential role in 
regulation of the cell cycle (Hershko, 2005) and transcription (Auld and Silver, 
2006; Muratani and Tansey, 2003), in modification of synaptic plasticity (Yi and 
Ehlers, 2005), and in cellular protein quality control (de Vrij et al., 2004; 
Goldberg, 2003; Kopito, 2000; Scheper and Hol, 2005; Varshavsky, 2005).
1.4.2 Autophagy-lysosome system
 Studies have also shown that the UPS only degraded the soluble form 
(Betarbet et al., 2005) but not   fibrillar forms of the aggregated proteins 
(Stefanis et al., 2001). In order to remove the fibrillar protein aggregates, cells 
adopt another protein quality control system, the autophagy-lysosome system. 
Unlike the ubiquitin-proteasome system mainly for the degradation of short-
lived proteins, the autophagy-lysosome system is responsible for the 
degradation of long-lived proteins, organelles turn-over, and the cellular 
survival response to starvation (Reggiori and Klionsky, 2005). Generally, the 
initial step of autophagy is the formation of the autophagosome, which is a 
double membrane structure containing several autophage-related proteins 
(Atgs). The conjugation of Atg12 and Atg5 is responsible for the double 
membrane elongation (Reggiori and Klionsky, 2005). Subsequently, the outer 
membrane fuses with a lysosome and the cargos within the autophagosome 
are released to be degraded (Levine and Yuan, 2005). Additionally, it has been 
shown that the deficiency of autophagy-lysosome system induces aggresomes 
to inclusion bodies (Kopito, 2000).
 Autophagy can be classified as two types, selective and non-selective 
autophagy, based on the different sources of stimulation. Selective autophagy 
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is initiated by intracellular components; non-selective autophagy is triggered 
by extracellular stimuli, such as starvation (Reggiori and Klionsky, 2005). In 
addition, autophagy can be  cataloged as macroautophagy, microautophagy, 
and chaperone-mediated macroautophagy (CMA) (Larsen and Sulzer, 2002) 
(Figure 1.5). Under cell stress or starvation, macroautophagy is initiated to 
degrade bulk proteins, and chaperone-mediated macroautophagy is triggered 
to specifically remove proteins with a KFERQ motif. Microautophagy 
functions under basal conditions to eliminate cytoplasmic proteins. A recent 
study has shown that autophagy can be triggered by the impairment of the 
UPS to degrade aggresomes in mammalian cells as well (Iwata et al., 2005a; 
Iwata et al., 2005b). Interestingly, activation of macroautophagy is mTOR 
activity-dependent and it has been suggested that macroautophagy functions 
as a compensatory response to the malfunction of the UPS in neurons (Rideout 
et al., 2004) (Figure 1.6). Studies have demonstrated that following the 
inhibition of proteasome activity neuronal autophagy is initiated in cultured 
neuroblastoma cells (Ding et al., 2003), suggesting that cells protect themselves 
from stress by activation of the lysosomal system (Larsen and Sulzer, 2002).
1.4.3 Neurodegenerative diseases
 Studies have reported that many chronic neurodegenerative diseases 
correlate with accumulation of ubiquitin-conjugated protein inclusion bodies, 
such as Alzheimer's disease (AD) with neurofibrillary tangles, Parkinson's 
disease (PD) with brainstem Lewy bodies (LBs), Amyotrophic Lateral Sclerosis 
(ALS) with Bunina bodies, Huntington's disease with polyglutamine extension 
(Poly-Q) in nuclear inclusions, Spinocerebellar Ataxias (SCAs), and Spinal and 
Bulbar Muscular Atrophy (SBMA; Kennedy's disease)
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Figure 1.5 | Different types of autophagy.
Microautophagy refers to the sequestration of cytosolic components directly 
by lysosomes through invaginations in their limiting membrane. The function 
of this process in higher eukaryotes is not known, whereas microautophagy-
like processes in fungi are involved in selective organelle degradation. In the 
case of macroautophagy, the cargoes are sequestered within a unique 
doublemembrane cytosolic vesicle, an autophagosome. Sequestration can be 
either nonspecific, involving the engulfment of bulk cytoplasm, or selective, 
targeting specific cargoes such as organelles or invasive microbes. The 
autophagosome is formed by expansion of the phagophore, but the origin of 
the membrane is unknown. Fusion of the autophagosome with an endosome 
(not shown) or a lysosome provides hydrolases. Lysis of the autophagosome 
inner membrane and breakdown of the contents occurs in the autolysosome, 
and the resulting macromolecules are released back into the cytosol through 
membrane permeases. CMA involves direct translocation of unfolded 
substrate proteins across the lysosome membrane through the action of 
acytosolic and lysosomal chaperone hsc70, and the integral membranereceptor 
LAMP-2A (lysosome-associated membrane protein type 2A). †From 
(Mizushima et al., 2008), courtesy of the author.
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Figure 1.6 | The role of autophagy in protecting against neuronal cell death. 
Certain key neuronal proteins may misfold. These misfolded proteins can 
become ubiquitinated (red circles) and degraded by the proteasome. However, 
these proteins may be poor substrates for the proteasome, and instead will 
accumulate in the cytoplasm, form aggregates and possibly leading to cell 
death. Basal autophagy can keep the levels of these proteins low enough to 
prevent toxic effects by sequestering them inside autophagosomes that deliver 
them to the lysosome for subsequent degradation. The misfolded proteins 
may also form large aggregates or inclusion bodies that can induce an 
autophagic response. These large aggregates may be more protective than 
harmful. †From (Klionsky, 2006), couresy of the author.
(Alves-Rodrigues et al., 1998; Sherman and Goldberg, 2001). However, the 
pathological significance of the protein inclusions remains unclear. Some 
studies in PD showed that accumulation of ubiquitin conjugates in LBs could 
be a secondary effect resulting from the impairment of    the UPS. The 
accumulation process may involve several cellular machineries, including 
formation of aggresomes (Johnston et al., 1998), and relocalization of 
proteasome to aggregates, to clear the abnormal protein inclusions (Fabunmi 
et al., 2000). In addition, recent studies indicate that the UPS can be inhibited 
by soluble aggregated protein inclusions (Bence et al., 2001). Conversely, some 
studies suggest that the concentration of ubiquitin conjugates in inclusion 
bodies is a protective mechanism and may separate the aggregates from the 
vulnerable cellular machineries.
 In summary, the affected regions with the presence of protein inclusions 
and the content of the   protein aggregates are disease-specific in 
neurodegenerative disorders. The cellular mechanisms behind the pathology 
remain poorly understood.
1.4.3.1 Alzheimer's Disease (AD)
 In 1906, Alois Alzheimer first delineated the neuropathological changes 
in AD involving abnormal protein aggregation with gradual neuronal loss and 
progressive dementia. The protein aggregates in AD are characterized as 
extracellular amyloid plaques and intracellular neurofibrillary tangles (Hardy 
and Selkoe, 2002). The extracellular aggregates are rich in amyloid β  peptides 
(Aβ) resulting from proteolytic cleavage of the cellular surface protein amyloid 
precursor peptide (APP) by β  and γ secretase functioning at specific sites. 
Hence, the cleaved fragments (Aβ1−40 or Aβ1−42) misfold and form the 
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extracellular amyloid plaques. The intracellular aggregates of the 
neurofibrillary tangles are rich in Tau protein. Tau protein undergoes 
increased hyperphosphorylation during the formation of neurofibrillary 
tangles. Interestingly, mutant APP but not mutant tau is sufficient to cause AD, 
indicating that accumulation of Aβ is the central event of AD pathogenesis.
Alzheimer's disease and the UPS
 Aβ  is normally degraded via the UPS in cultured neurons and 
astrocytes and inhibition of the UPS increases Aβ-induced cell death (Lopez 
Salon et al., 2003). Studies have shown that AD patients exhibit the 
impairment of proteasome activity in the brain (Keller et al., 2000) as well as a 
reduced activity of E1 and E2 enzymes in cerebral cortex (Lopez Salon et al., 
2000). However, some studies show that amyloid has no effect on proteasome 
activity (Lue et al., 1999); other reports show that no alteration of proteasome 
activity is found in AD patients (Blandini et al., 2006). In addition, it remains 
unknown whether the impairment of the UPS activity cause Aβ  plaques, or 
Aβ/Tau leads to proteasome inactivation.
Alzheimer's disease and Autophagy
 Before the formation of amyloid plaque, upregulated endocytic-
lysosomal and autophagy-lysosomal system is also found in AD (Cataldo et 
al., 1995; Nixon et al., 2005)  to successfully remove the aggregated proteins 
(Nixon et al., 2005). However, as the disease progresses, the decreased 
efficiency of lysosomal system (Yu et al., 2005)  and the failure of fusion of 
autophagosome to lysosomes leads to numerous autophagosomes 
accumulated in neurons (Nixon et al., 2005). A recent report has proposed that 
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the autophagosomes may eventually become the internal source for Aβ 
deposition because they contain the APP on the membrane and secretases (Yu 
et al., 2005).
1.4.3.2 Amyotrophic Lateral Sclerosis (ALS)
 The neuropathology of ALS has been well characterized with primarily 
neuronal death of brainstem and spinal motorneurons, corticospinal 
degeneration, and paralysis of skeletal muscle. The mutations in all ALS are 
involved in the gene coding for Copper-Zinc superoxide dismutase (SOD1) 
(Valentine and Hart, 2003), which scavenges oxygen radicals to prevent cells 
from oxidative stress.
Amyotrophic lateral sclerosis and the UPS
 The mutant SOD1 proteins tend to be more insoluble (Johnston et al., 
2000; Shinder et al., 2001) and form polyubiquitinated aggregates in Bunina 
bodies, consisting of proteasome and neurofilaments (Alves-Rodrigues et al., 
1998; Johnston et al., 2000). Unlike other neurodegenerative protein inclusions, 
the mutant SOD1 aggregates do not cause cell death (Lee et al., 2002) and can 
be further degraded by the UPS (Hoffman et al., 1996; Johnston et al., 2000). 
Although its role remains unclear, the accumulation of mutant SOD1 
aggregates is enhanced by impairment of defense against oxidative stress and 
inhibition of the UPS (Lee et al., 2002). A recent study has shown that the 
expression of mutant SOD1 induces oxidative stress to cells (Hyun et al., 
2003). In addition, over-expression of the E3 ligase dorfin can facilitate the 
removal of mutant SOD1 via the UPS, leading to increased cell survival (Niwa 
et al., 2002). In ALS patients' spinal cord, it is often found that an increase of 
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dorfin expression (Ishigaki et al., 2002). It has been proposed that under 
increasing oxidative stress, the cell accumulates the mutant SOD1 protein 
inclusions more quickly   and the accumulating mutant SOD1 protein 
inclusions can eventually inhibit the UPS (Urushitani et al., 2002). 
Consequently, the inhibition of the UPS increases the mutant SOD1 protein 
inclusions to form aggresomes (Johnston et al., 2000).
1.4.3.3 Parkinson’s Disease (PD)
 The neuropathological character of PD is the progressive and extensive 
loss of dopaminergic neurons in the area of substantia nigra pars compacta 
and the stratium. Many dopaminergic neurons also present intracellular 
aggregated proteins, such as α-synuclein, in Lewy bodies (Nussbaum and 
Polymeropoulos, 1997; Pollanen et al., 1993).   It has been proposed that 
mitochondrial dysfunction mediated oxidative stress and impairment in the 
major proteolytic systems both contribute to the accumulation of protein 
aggregates, which is responsible for loss of dopaminergic neurons (Abou-
Sleiman et al., 2006; Betarbet et al., 2005). Studies have shown that mutations 
in DJ-1 (Mitsumoto and Nakagawa, 2001) or PINK1 (Valente et al., 2004) lead 
to mitochondrial dysfunction, causing increased oxidative stress. Besides, 
mutations in  Parkin (Kitada et al., 1998),  UCH-L1 (McNaught et al., 2002b), 
components of the ubiquitin-proteasome system, and ATP13A2 (lysosomal 
ATPase) (Ramirez et al., 2006)   can result in deficiency in protein quality 
control systems. Interestingly, recent studies have revealed that a   genetic 
interaction between Parkin and PINK (Pallanck and Greenamyre, 2006; Park et 
al., 2006). In summary, the death for dopaminergic neurons may result from 
36
loss-of-function of several different proteins because of their aggregation or 
the toxic gain-of-function of the aggregated protein inclusions.
Parkinson’s Disease and the UPS
 In PD, the UPS is highly involved in the pathogenesis of 
neurodegeneration. Parkin (PARK2) is one of the important molecules 
involved in the pathogenesis of PD. It has been identified as an ubiquitin-
protein ligase functioning with UbcH7 and UbcH8 (Imai et al., 2000; Shimura 
et al., 2001). Parkin can recruit E2 ligase of the ubiquitination machinery as 
well as associate with RPN10 (S5a) subunit of the 26S proteasome (Sakata et 
al., 2003; Upadhya and Hegde, 2003). Therefore, Parkin transfers the 
polyubiquitnated substrates to the degradation machinery. Additionally, 
inactivation of Parkin or deficiency in interaction of Parkin with its partners 
has been proposed to play key role in PD pathogenesis (Dawson and Dawson, 
2003; Dev et al., 2003; McNaught and Jenner, 2001; Mizuno et al., 2001). Hence, 
mutant Parkin could cause accumulation of abnormal proteins, resulting in 
death of dopaminergic neurons. An in vivo study has shown that Drosophila 
with Parkin knockout presents reduced life span, locomotor disorders, and 
selective male sterility (Greene et al., 2003). Of which, the locomotor disorder 
is caused by  mitochondrial dysfunction in muscle cells. It is known that 
mitochondrial dysfunction often leads to cell death.
 One of the most common familial forms of PD is AR-JP (autosomal-
recessive Parkinson's disease [ARPD]) (Kitada et al., 1998). Various deletion 
and point mutations of Parkin lead to its inactivation (Lucking et al., 2000) or 
loss of the ability to interact with partners, such as CHIP (carboxy-terminus of 
the sc70-Interacting protein) (Imai et al., 2002). A recent study has suggested 
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that insufficient activity of Parkin causes some cases of AR-JP (West et al., 
2002). In addition, studies have characterized several Parkin substrates linked 
to AR-JP, including  cell-division control related protein (CDCrel-1) (Zhang et 
al., 2000), Parkin-associated endothelial- like (Pael) receptor (Imai et al., 2001), 
22 kDa form of O-glycosylated α-Synuclein (αSp22) (Shimura et al., 2001), 
Synphilin-1 (Chung et al., 2001), polyglutamine Ataxin-3 fragment (Tsai et al., 
2003), and cyclin E (Staropoli et al., 2003). Although these substrates are 
regulated by Parkin-mediated polyubiquitination, it is still unclear whether 
Parkin-inactivation-induced accumulation of these proteins play a role in 
cytotoxicity to dopaminergic neurons.
 As mentioned above, αSYN (also termed PARK1) is one of the Parkin 
substrates and identified as another important molecule causing PD via its 
mutant affecting the UPS activity. In PD patients, αSYN is often found at high 
intracellular concentration which leads to protein oligomerization (Singleton 
et al., 2003). The oligomerization of αSYN further results in progressive 
aggregation of αSYN fibrils in Lewy bodies (Conway et al., 2000). Hence, the 
αSYN protein aggregates increase the sensitivity of neuronal cell to toxic 
agents as well as inhibit proteasome activity, leading to cell apoptosis (Lee et 
al., 2001). Moreover, it has been shown that normal and aggregated αSYN can 
both interact with S6′ subunit of proteasome to further inhibit proteasomal 
function (Bence et al., 2001; Snyder et al., 2003). Malfunctional αSYN may also 
affect its associated proteins, such as Synphilin (Chung et al., 2001) and 
tyrosine hydroxylase (Doskeland and Flatmark, 2002) to disturb neuronal 
homeostasis and develop neurodegeneration.
 There is increasing evidence suggesting deficient the UPS in PD. Studies 
have shown that loss of α subunits of the 26S proteasome (McNaught et al., 
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2002a) impairs the proteasomal catalytic activity in sporadic PD (McNaught 
and Jenner, 2001). In addition, decreased 19S/PA700 proteasome activator as 
well as the PA28 regulator are found in the brain of PD patients (McNaught et 
al., 2003).
Parkinson’s Disease and Autophagy
 Aside from the UPS, αSYN can be degraded by CMA as well (Webb et 
al., 2003). However,  αSYN mutants bind to the CMA with high affinity, 
resulting in blockage of cargo transfer and substrate degradation (Cuervo, 
2004). Hence, normal substrate proteins in CMA cannot be turned over and 
accumulate in cells (Cuervo, 2006). Interestingly,  inhibition of the ubiquitin-
proteasome system and CMA can increase activity of macroautophagy (Iwata 
et al., 2005b; Massey et al., 2006) to eliminate both the cytosolic toxic and 
aggregated αSYN (Rideout et al., 2004).
1.4.3.4 Polyglutamine diseases
 The pathogenetic character of polyglutamine diseases is a mutation with 
the CAG triplet repeat expansion (Gusella and MacDonald, 2000). Although 
various combinations of motor, psychiatric, cognitive, and sensory symptoms 
may exhibit in the different polyglutamine expansion (Nakamura et al., 2001; 
Ross, 2002; Taylor et al., 2002; Zoghbi and Orr, 2000), most of the 
polyglutamine diseases are autosomal-dominant and have specific disease-
related misfolded proteins in inclusions. These diseases are considered as a 
gain in toxicity from accumulating cytoplasmic or intranuclear protein 
inclusions (Ross, 1997; Scherzinger et al., 1997; Zoghbi and Orr, 2000). The 
process of polyglutamine-containing protein accumulation involves multiple 
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steps, including a nucleation event (Perutz and Windle, 2001), action of 
transglutaminase (Kahlem et al., 1996), transfer of  polyglutamine-containing 
protein via the microtubule organization center (MTOC or centrosomes) to a 
perinuclear localization (Hoffner et al., 2002; Waelter et al., 2001).
 Among these polyglutamine diseases, Huntington’s disease (HD) is the 
best studied disorder (Landles and Bates, 2004). The neuropathic features of 
HD are death of neuronal cells, progressive cognitive impairment, 
abnormality of movement, and intraneuronal inclusion bodies of mutant 
Huntingtin (Kegel et al., 2000). Mutant Huntingtin is because of genetic 
polyglutamine expansion in the N-terminal sequence of Huntingtin (Zuccato 
et al., 2003). The mutant Huntingtin forms aggregates and promotes 
aggregation of the wild-type Huntingtin (Ambrose et al., 1994; Busch et al., 
2003). Because Huntingtin involved in different intracellular processes, such as 
gene transcription and intracellular trafficking (Li and Li, 2004) via interacting 
with various proteins at its N-terminal region, the aggregation of Huntingtin 
with other proteins increase the effect of loss-of-function (Cha, 2000; 
Gidalevitz et al., 2006).
Polyglutamine diseases and the UPS
 Studies have indicated that several elements of the UPS are co-
aggregated with different disease-specific polyglutamine proteins (Chai et al., 
1999; Cummings et al., 1998; Schmidt et al., 2002; Stenoien et al., 1999; Stenoien 
et al., 2002; Verhoef et al., 2002; Waelter et al., 2001). For instance, ubiquitinated 
Huntingtin interacts with the E2 enzyme (Kalchman et al., 1996), Ataxin-7 
associates with the S4 subunit of the proteasome (Matilla et al., 2001), and 
Ataxin-3 binds to the shuttle protein Rad23 and the S5a subunit (Doss-Pepe et 
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al., 2003). From an in vivo report, transgenic Ube3a null mice which express 
mutant Ataxin-1 exhibit less intranuclear aggregates within neurons 
(Cummings et al., 1999) owed to the deficiency of polyubiquitination on 
Ataxin-1. In addition, in vitro studies show that over-expression of mutant 
Huntingtin causes inhibition of proteasome activity (Bence et al., 2001; Ding et 
al., 2002) and expression of truncated Huntingtin aggregates more rapidly 
when the proteasome activity is pharmacologically inhibited (Lunkes et al., 
2002). Furthermore, there are several studies showing that reducing 
transglutaminase activity in the brain can prolong life span of the R6/2 
transgenic mouse model of HD (Dedeoglu et al., 2002; Karpuj et al., 2002), 
suggesting that polyglutamine-expansion proteins may be stabilized by the 
reaction of transglutaminase. Therefore, the transglutaminase-modified 
polyglutamine-containing proteins block the proteasome and they are free 
from degradation by the UPS system. More interestingly, a study using 
cultured mouse neuroblastoma cells reported that mutant Huntingtin inhibits 
the proteasome catalytic activity, p53 degradation, and normal mitochondrial 
membrane potential, leading to release of cytochrome c, activation of caspase-
cascade, and apoptosis (Jana et al., 2001).
Polyglutamine diseases and Autophagy
 Studies have shown that striatal neurons derived from R6/2 transgenic 
HD mice exhibit increased autophagy (Petersen et al., 2001). In addition, 
deficiency in macroautophagy is found to associate with Huntington's disease 
(Qin et al., 2003; Ravikumar et al., 2002) and the formation of Huntingtin 
aggregates (Qin et al., 2003; Ravikumar et al., 2002; Shibata et al., 2006). 
Furthermore, activation of macroautophagy facilitates the removal of 
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Huntingtin, improving the neurological symptoms in mouse models of 
Huntington's disease (Ravikumar et al., 2004).
1.4.3.5 Prion Disease
 In 1982, Stanley Prusiner originally proposed a proteinaceous infectious 
hypothesis to describe the underlying mechanism of Prion diseases. Owed to 
the unique conformational change of the brain, the Prion disease is also named 
as transmissible spongiform  encephalopathies (TSEs). TSEs includes bovine  
spongiform encephalopathy (BSE) in cattle (Lampert et al., 1972), Scrapie in 
sheep and goats (Lampert et al., 1972), chronic wasting disease (CWD) in elk 
and deer (Johnson, 2005; Lampert et al., 1972), as well as Creutzfeld-Jakob 
disease (CJD) (Ironside et al., 1993; Lampert et al., 1972; Masters and 
Richardson, 1978; Piccardo et al., 1990; Voigtlander et al., 2001), fatal familial 
insomnia (FFI) (Glatzel et al., 2005; Johnson, 2005; Lampert et al., 1972), 
Gerstmann-Sträussler-Scheinker disease (GSS) (Glatzel et al., 2005; Johnson, 
2005; Lampert et al., 1972), and kuru in human (Lampert et al., 1972; Piccardo 
et al., 1990). The neuropathology of Prion disease is characterized by extensive 
neuronal cell death, spongiform degeneration, reactive gliosis, and 
extracellular amyloid aggregates. Therefore, Prison disease progressively 
develops motor disturbance and dementia causing death.
 The normal prion protein (PrP) is called PrPC, which is particularly 
abundant in the immune and nervous systems and functions as a copper 
binding protein with antioxidative activity (Brown, 2002). PrPC associates with 
chaperone BiP during protein folding (Jin et al., 2000) and normally undergoes 
degradation by the UPS via endoplasmic reticulum associated protein 
degradation (ERAD) (Yedidia et al., 2001; Zanusso et al., 1999). In TSEs, PrPC is 
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misfolded to its insoluble format, PrP-scrapie (PrPSc). The conformational 
change from PrPC to PrPSc can be further induced by PrPSc. Consequently, the 
accumulating PrPSc isoform causes cell death, resulting in release of PrPSc 
which can affect the neighboring cells.
 Polyubiquitin protein inclusions have been found in CJD brains (Ironside 
et al., 1993), suggesting an overload of the UPS or a decrease of proteasome 
activity. Additionally, it has been suggested that malfunction of the UPS can 
trigger the accumulation of PrPC (Hooper, 2003) in the ER, Golgi apparatus, 
and nucleus, where PrPC is converted into PrPSc (Hooper, 2003; Ma and 
Lindquist, 2002; Ma et al., 2002). On the one hand, a study in PrPC knockout 
mice indicates that transmitted PrPSc has no toxicity resulting from the absence 
of PrPC (Bueler et al., 1993). However, the transgenic mice over-expressing 
normal PrPC could generate PrPSc protein inclusions, leading to progressive 
cerebellar degeneration and ataxia (Ma et al., 2002). Besides the UPS, it has 
been demonstrated that autophagy is responsible for general synaptic loss in 
CJD brains (Sikorska et al., 2004), but there is no deficiency of autophagy 
reported yet. 
1.5 TNFα pathway
 Although tumor necrosis factor (TNF) was known for its anticancer 
activity more than a century ago, the human TNF cDNA was first cloned in 
1984. Since then, studies have shown that TNF play a role in  a number of 
biological processes including inflammation, proliferation, cell migration, 
apoptosis, and necrosis (Eissner et al., 2000; Eissner et al., 2004; Harashima et 
al., 2001; Ware, 2005). TNFα is synthesized as a monomeric transmembrane 
protein (tmTNF). It is then inserted into the plasma membrane as a 
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homotrimer, which is further modified by the matrix metalloprotease TNF 
alpha converting enzyme (TACE) to a soluble trimer (solTNF). TNFα can 
function in an autocrine or paracrine fashion. In the CNS, microglias, 
astrocytes and several types of neurons can produce tmTNF and solTNF 
(Chung et al., 2005; Lieberman et al., 1989; Morganti-Kossman et al., 1997). 
Studies have also shown that both tmTNF and solTNF are biologically active 
(Idriss and Naismith, 2000; MacEwan, 2002). In TNFα signaling, there are two 
distinct transmembrane receptors, TNF receptor-1 (TNF-R1, Tnfrsf1a) and 
TNF receptor-2 (TNF-R2, Tnfrsf1b). Although they specifically bind TNFα 
ligands, the two receptors differ in expression pattern, affinity for ligand, 
their structures of intracellular domains (Chan et al., 2000; Engelmann et al., 
1990), and downstream signaling pathways, which give rise to their distinct 
responses to TNFα stimulation. For example, TNF-R2 is mainly expressed in 
the immune system and endothelial cells and it is activated by tmTNF 
preferentially (Grell, 1995; Grell et al., 1998). In contrast, TNF-R1 is widely 
expressed in numerous cell types and the receptor can be activated by tmTNF 
or solTNF. TNF-R1 activation by solTNF is thought to be the initiation of 
TNFα-mediated several cellular responses (Locksley et al., 2001) (Figure 1.7).
1.5.1 TNF-R1 signaling
 In the beginning of TNF-R1 signaling, the extracellular domain of TNF-
R1 binds to the TNFα trimer, which leads to the dissociation between silencer 
of death domains (SODD) and the intracellular domain of TNF-R1 (death 
domain, DD). The intracellular domain of TNF-R1 further interacts with an 
adaptor protein, TNF receptor-associated death domain (TRADD) (Tartaglia et 
al., 1993; Ware et al., 1996). In addition, TRADD recruits several proteins,
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Figure 1.7 | TNF-mediated death and survival pathways are activated 
following interaction with the TNFRs.
The apoptotic pathway is activated through TNFR1 by forming the DISC, 
which activates caspase-8. Activated caspase-8 or −10 then activates the 
proapoptotic Bcl-2 family members, which leads to cell death by releasing 
cytochrome c from mitochondria and loss of MMP. The NF-κB-mediated 
survival pathway is activated by both TNF-R1 and TNF-R2. Association of 
TRAFs with these receptors activate signaling proteins like NIK (NF-κB 
inhibitor kinase) and MEKK1 (MAPK kinase 1), which activate the inhibitor of 
NF-κB (IkB) kinase (IKK) complex. IKK phosphorylates IkB, resulting in the 
degradation of the inhibitor. The free NF-κB than translocates to nucleus to 
induce the expression of inflammatory or anti-apoptotic genes. †From 
(Rahman and McFadden, 2006), courtesy of the author.
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including receptor-interacting protein (RIP), TNF-R-associated   factor 2 
(TRAF2) (Hsu et al., 1996a; Hsu et al., 1996b; Hsu et al., 1995; Jiang et al., 1999), 
and Fas-associated death domain (FADD), to form a protein complex with 
TNF-R1. After the formation of the protein complex, TNF-R1 activates 
biological events by recruiting several signaling molecules, such as caspase-8, 
cellular inhibitor of apoptosis protein-1 (cIAP-1), cellular inhibitor of apoptosis 
protein-2 (cIAP-2), extracellular signal regulated kinase kinase kinase 1 
(MEKK1), and apoptosis-stimulated kinase 1 (ASK-1). 
 The TNF-R1 protein complex can initiate cell survival signaling via 
TRAF2. TRAF2   activates MEKK1 and ASK1, ultimately resulting in 
phosphorylation of c-Jun NH2-terminal   kinase (JNK). The activated JNK 
further phosphorylates c-Jun, increasing   transcriptional activity of c-
Jun.  Interestingly, studies on TNF-induced JNK activation have shown that 
transient activation of JNK is TAK1-dependent and cytoprotective (Sato et al., 
2005); however, sustained activation of JNK is ASK1 dependent and leads to 
caspase-dependent apoptosis (Tobiume et al., 2001).   Some studies also 
documented that degradation of TRAF2 by cIAP-1 increases the sensitivity of 
cell to TNFα-induced apoptosis (Li et al., 2002). Additionally, cIAP-1 can also 
regulate apoptosis through mediating the ubiquitination and degradation of 
proapoptotic proteins, such as Smac/DIABLO (Hu and Yang, 2003).  Other 
than cIAP-1-induced apoptosis, TNF-R1 can be internalized after associating 
with ligands, which leads to dissociation of the TRADD/TRAF2/RIP complex 
and association of FADD. The interaction of TNF-R1 with FADD 
further   recruits caspase-8 to form the   death-inducing signaling complex 
(DISC), which trigger the activation of caspase-8. The activation of caspase-8 
further initiates an extrinsic protease-dependent apoptosis (Micheau and 
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Tschopp, 2003; Schneider-Brachert et al., 2004) as well as 
an   intrinsic  mitochondrial-induced apoptosis pathway by cleaving Bax and 
Bid (Gross et al., 1999; Wang et al., 2006; Zhao et al., 2001).
 In the TNF-R1 pathway, RIP is known as another crucial molecule 
responsible for the activation of the transcription factor NF-κB to initiate pro-
survival signaling, cellular proliferation, and cytokine production.   The 
inactive form of NF-κB is normally associated with its inhibitor, inhibitor of κB 
(IκB), which retains NF-κB within the cytoplasm. Upon TNFα stimulation, 
RIP activates a multi-protein IκB kinase (IKK) complex (Ghosh and Karin, 
2002), consisting of Cdc37, Hsp90, IKKα and IKKβ, and IKKγ (NEMO). Cdc37 
and Hsp90 function as a shuttle to translocate the protein complex from the 
cytoplasm to the membrane where the catalytic subunits of IKK protein 
complex, IKKα and IKKβ, phosphorylate IκB (Chen et al., 2002). Once it is 
phosphorylated, IκB undergoes ubiquitination and degradation. Hence, NF-
κB becomes active and translocates to the nucleus to initiate the transcriptional 
events. Finally, studies using transgenic mice have demonstrated that IKKβ is 
responsible for activation of NF-κB, and IKKγ plays a role in regulation of IKK 
complex activation upon TNFα stimulation (Ruocco et al., 2005).
 More interestingly, there is a delicate cross talk between NF-κB and JNK 
signaling in the TNF-R1 pathway. TNFα-induced JNK activation  becomes 
higher and sustained in NF-κB null cells. Conversely, NF-κB-activated genes 
generate proteins to inhibit the activation of JNK. In addition, activation of 
NF-κB leads to increased synthesis of its inhibitory molecules, including IkB 
and cIAPs. Therefore, cellular functions are fine-tuned by TNF-R1 pathway.
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1.5.2 TNFα signaling in CNS
 Studies have shown that TNF signaling regulates several functions 
within the brain, including injury-mediated activation of microglia and 
astrocytes, permeability of the blood brain barrier, febrile responses, 
glutamatergic transmission, as well as synaptic plasticity and scaling (Beattie 
et al., 2002; Leon, 2002; Merrill, 1991; Pickering et al., 2005; Sedgwick et al., 
2000; Selmaj et al., 1990; Stellwagen et al., 2005; Stellwagen and Malenka, 
2006). In the CNS, TNFα signaling actually presents a dual role in 
neurotoxicity and neuroprotection.   Owed to   the differential expression 
patterns of TNF receptors on neuronal and glial cells, the ultimate TNFα-
triggered biological effect depends on the areas of the brain or the types of 
neuronal cells (Akassoglou et al., 2003; Dopp et al., 1997; Dziewulska and 
Mossakowski, 2003; Fontaine et al., 2002; Sairanen et al., 2001). For example, 
the activation of NF-κB is linked to TNFα-mediated neuroprotection (Albensi 
and Mattson, 2000; Barger et al., 1995; Kaltschmidt et al., 1999); the reduced 
activity of NF-κB is associated with neurotoxicity (Botchkina et al., 1999; 
Sriram et al., 2002). Studies have shown that TRAF2 and the stress response 
gene   BRE (brain, and reproductive organ expressed) are involved in the 
regulation of NF-κB activation in TNF-R1 signaling (Gu et al., 
1998).  The   cortical neurons derived from TNFα-overexpressed mice show 
activation of NFκB, which protects cells from glutamate toxicity and increases 
neuronal survival (Marchetti et al., 2004). In addition,  the TNF-R2-deficient 
neurons are shown to be more sensitive to both TNFα and glutamate-induced 
death (Marchetti et al., 2004). In contrast, TNFα-deficient mice 
exhibit accelerated maturation of the dentate gyrus area and shorter dendritic 
arbors in the hippocampus (Golan et al., 2004), indicating that TNFα regulates 
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hippocampal neuronal development. More interestingly, in many 
neurodegenerative disorders, such as AD (Alvarez et al., 2007; Fillit et al., 1991; 
Paganelli et al., 2002) and PD (Bessler et al., 1999; Boka et al., 1994; Hirsch et 
al., 1998; Mogi et al., 1994; Mogi et al., 2000; Nagatsu et al., 2000), the 
neuropathies of the diseases associate with increased solTNF in the brain. 
Hence, owed to the presence of TNFα at the place with neuronal damage, it 
may be useful to develop therapeutic treatments for acute and chronic 
neurodegenerative disorders by targeting TNFα.
1.5.3 TNF-R1 in Alzheimer's disease
 In AD patients, TNFα is found within the amyloid plaques (Dickson, 
1997) consistent with the findings from the transgenic Tg2576 mice over-
expressing a mutated form of human amyloid precursor protein (APP) that 
high levels of TNFα are present in amyloid plaques (Mehlhorn et al., 2000; 
Munch et al., 2003; Sly et al., 2001). Furthermore, deletion of TNF-R1 in APP23 
transgenic mice which overexpress APPKM670/671NL   can reduce Aβ 
accumulation, activation of microglia, loss of neurons, and memory deficits 
(He et al., 2007).
1.5.4 TNF-R1 in Parkinson's disease
 Similar to many other neurodegenerative diseases, the levels of TNFα 
and solTNF-R1 are increased in PD patients. The areas with higher levels of 
TNFα and solTNF-R1 also present more loss of dopaminergic neurons (Boka et 
al., 1994; Hirsch et al., 1998; Mogi et al., 1994; Mogi et al., 2000), consistent with 
the findings from in vitro (Clarke and Branton, 2002; Gayle et al., 2002; 
McGuire et al., 2001) and in vivo (Aloe and Fiore, 1997; Carvey et al., 2005) 
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studies showing neurotoxicity of TNFα to dopaminergic neurons. Taken 
collectively, the results suggest that TNF-R1 signaling plays a role in the 
progressive loss of neurons in PD. 
1.6 Project Overview
 After the first decade of its discovery, FIP200 has been shown to regulate 
various cellular functions, such as proliferation, spreading, migration, cell 
growth and size regulation, autophagy, and survival. However, little is known 
about the role of FIP200 in CNS. In the brain, neuronal cell proliferation, 
migration, and cell death are essential processes required for normal brain 
function. Therefore, my project has focused on the analysis of FIP200 functions 
in CNS by using in vivo mice genetics approaches to test whether FIP200 is 
required for neuronal cell survival and to discover the possible mechanisms 
by which FIP200 regulates neuronal functions.
 To bypass embryonic lethality caused by total deletion of FIP200 and to 
investigate the role of FIP200 in CNS, I initially generated transgenic mice in 
which the ablation of FIP200 in CNS is mediated by Cre recombinase driven 
by the nestin promotor. In the Nestin-CKO transgenic mice, the deletion of 
FIP200 occurs in the neurons and glial cells. As detailed in Chapter 2, this 
conditional knockout of FIP200 led to several neuropathologies, including 
ubiquitin aggregates, vacuolization changes, reactive gliosis, axonal swelling 
and degeneration, and increased cell death. Interestingly, these mice 
developed cerebellar ataxia and their Purkinje cells were degenerated as well. 
 Therefore, to characterize whether the cerebellar ataxia is resulting from 
deletion of FIP200 in the Purkinje cells, I further generated the transgenic mice 
of which the deletion of FIP200 is mediated by Cre recombinase driven by 
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hGFAP promotor. As detailed in Chapter 3, these mice did not exhibit any 
degeneration of the Purkinje cells by 8 weeks. In addition, I generated the 
transgenic mice in which the deletion of FIP200 is mediated by Cre 
recombinase driven by L7 promotor. In the cerebellum of L7-CKO transgenic 
mice, the Purkinje cells are the only population without expression of FIP200. 
This conditional knockout of FIP200 led to similar neuropathologies as nestin-
CKO mice, including ubiquitin aggregates, vacuolization changes, reactive 
astrogliosis, axonal swelling and degeneration, and increased the Purkinje cell 
death. The transgenic mice also developed ataxia. To further investigate the 
mechanism by which deletion of FIP200 leads to loss of the Purkinje cells, I 
generated two different transgenic mice by using a double knockout strategy. 
One is specific ablation of FIP200 and p53 in the Purkinje cells. However, the 
double conditional knockout mice still exhibit loss of Purkinje cells and ataxia. 
These results suggest that the Purkinje cell death is not through p53-mediated 
apoptosis. The other is double deletion of FIP200 and TNF-R1 in the Purkinje 
cells. The double conditional knockout mice rescued the loss of Purkinje cells 
and vacuolization changes. I also found that deletion of FIP200 led to 
dysfunction of mitochondria, releasing cytochrome c. Interestingly, inaction of 
TNFR-1 reduced cytochrome c release in the L7-CKO. Taken together, the data 
indicate that TNFR-1-FIP200 pathway is responsible for Purkinje cell survival.
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Chapter 2
CHARACTERIZATION of CEREBELLAR DEGENERATION 
MEDIATED by ABLATION of FIP200 
2.1 Introduction
 The cerebellum provides central control of posture, balance, and 
coordination of movements. Cerebellar development initiates during 
embryogenesis but extends into early postnatal development to achieve the 
highly organized cerebellar cortex (Kandel et al., 2000). Consistent with their 
crucial roles in the control of movement coordination, damages to cerebellum 
caused by either injury or neurodegeneration are associated with various 
degrees of ataxia phenotype both in human as well as mouse models. Indeed, 
the dominantly inherited ataxias or spinocerebellar ataxias are one of the most 
common forms of neurodegenerative diseases caused by progressive 
degeneration of the cerebellum. Studies in the last decade have identified 
various gene mutations underlying the different neurodegenerative disorders 
and revealed a potentially common cellular mechanism of these diseases, i.e. 
the accumulation of abnormal protein aggregation based on converging lines 
of investigations (Ross and Poirier, 2004). Protein quality control mechanisms 
including the ubiquitin-proteasome system and autophagy have been shown 
to play crucial roles in the homeostasis of neurons and neurodegeneration 
(Giobbe et al., 1991; Winslow and Rubinsztein, 2008). However our 
understanding of the molecular and cellular mechanisms by which key 
signaling molecules and pathways regulate these cellular processes in 
neurodegeneration is still incomplete at present.
 FIP200 (FAK-family interacting protein of 200 kDa) (also called RB1CC1) 
is a 200 kDa protein that is characterized by a large coiled-coil region (Chano 
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et al., 2002b; Ueda et al., 2000). It was initially identified as a protein that 
interacts with Pyk2 and FAK leading to the inhibition of their kinase activities 
(Ueda et al., 2000) but has been shown to associate with several other cellular 
proteins and regulate several signaling pathways (Gan and Guan, 2008). 
FIP200 is widely expressed in various human tissues (Bamba et al., 2004) and 
is an evolutionarily conserved protein present in human, mouse, rat, frog, fly 
and worm. The high degree of conservation during evolution suggests 
potentially important functions of FIP200 in vivo. This is supported by our 
recent studies showing that total KO of FIP200 in mice resulted in embryonic 
lethality at mid/late gestation associated with heart failure and liver 
degeneration (Gan et al., 2006). Furthermore, it was recently reported that 
RNAi-mediated knockdown of FIP200 caused neurite atrophy and apoptosis 
in a neuroblastoma cell line Neuro-2a (Chano et al., 2007), suggesting that 
FIP200 may also play a role in neurons.
 To explore a potential role of FIP200 in neurodegeneration in vivo, 
neuron-specific conditional FIP200 KO mice were generated and analyzed 
using the Cre-loxP approach. I found that conditional KO of FIP200 by nestin-
Cre resulted in severe neurological defects including cerebellar degeneration 
and ataxia, which were accompanied by progressive loss of the Purkinje cells, 
spongiform degeneration, abnormal accumulation of ubiquitinated 
protein aggregates, and increased apoptosis in the cerebellum.
2.2 Material and Methods
Animals and genotyping
FIP200flox/flox mice were described previously (Gan et al., 2006). Nestin-Cre 
transgenic mice (Tronche et al., 1999) were obtained from The Jackson 
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Laboratory (Bar Harbor, ME). Mice were housed and handled according to 
local, state, and federal regulations, and all experimental procedures were 
carried out according to the guidelines of Institutional Animal Care and Use 
Committee at Cornell University and the University of Michigan. Mice 
genotyping for FIP200 and Cre alleles were performed by PCR analysis of tail 
DNA, essentially as described previously (Gan et al., 2006; Wei et al., 2009).
Protein extraction, SDS-PAGE and Western Blotting
The mouse brain tissues were collected from control or FIP200flox/flox; nestin-
Cre mice at P0. The protein lysates were prepared by homogenization in 
modified RIPA buffer (50 mM Tris-HCl, pH 7.4, 1% Triton X-100, 0.2% sodium 
deoxycholate, 0.2% sodium dodecylsulfate (SDS), 1 mM sodium 
ethylenediaminetetraacetate) supplemented with protease inhibitors (5 μg/ml 
leupeptin, 5 μg/ml aprotinin, and 1 mM phenylmethylsulfonyl fluoride). 
Tissue and cell debris were removed by centrifugation and cleared 
supernatants were further transferred into a clean microcentrifuge tube. 
Protein concentration was determined using Bio-Rad protein assay reagent. 
The lysates were boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl 
pH 6.8, 12.5% glycerol, 1% SDS, 0.01% bromophenol blue) containing 5% β-
mercaptoethanol and were then resolved with 6% polyacrylamide gel 
electrophoresis. After the SDS-PAGE were transferred onto a nitrocellulose 
membrane, membranes were incubated with antibody against FIP200 (1:1000) 
for 1 h at room temperature, washed using TBST, and incubated with the HRP 
anti-rabbit secondary antibodies (1:5000; Jackson ImmunoResearch 
Laboratories, Inc., West Grove, PA). An Enhanced Chemiluminescent (ECL) kit 
(Pierce) was used to detect the immunoreactivity signal.
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Histology and Immunohistochemistry  
Mice were euthanized using CO2, and a complete tissue set was harvested 
during necropsy. Fixation was carried out for 16 h at 4°C using freshly made, 
pre-chilled (4°C) PBS-buffered formalin. The brain tissues were all sagittal 
sectioned and then embedded in paraffin, sectioned at 6 μm, and stained with 
hematoxylin and eosin for routine histological examination or left unstained 
for immunohistochemistry. Hematoxylin- and eosin-stained sections were 
examined under an Olympus BX41 light microscope (Olympus America, Inc., 
Center Valley, PA), and images were captured with an Olympus digital camera 
(model DP70) using a DP Controller software (Version 1.2.1.10 [EC] 8). For 
immunohistochemistry, unstained tissue sections were first deparaffinized in 3 
washes of xylene (3 min each) and were rehydrated in graded ethanol 
solutions (100, 95, 70, 50, and 30%). After heat-activated antigen retrieval 
(model Retriever 2000, PickCellLaboratories B.V., Amsterdam, Holland) 
according to manufacturer's specifications, sections were treated with blocking 
solutions; first with Avidin-Biotin Block (Dako Corp., Carpinteria, CA) then 
with Protein Block Serum Free (Dako Corp.). Sections were then incubated 
with the primary antibody (calbindin 1:2000, Sigma-Aldrich; ubiquitin 1:500, 
Cell signaling; Dako Corp.; GFAP 1:1000, Dako Corp.; MBP 1:1000, Millipore) 
at 37 °C for 1 h in a humid chamber, washed in PBS 3 times (5 min each), then 
incubated with the biotinylated secondary antibody anti-mouse for calbindin, 
ubiquitin (Cell signaling); anti-rabbit for FIP200, GFAP, ubiquitin (Dako 
Corp.); anti-rat (Vector) for MBP   (1:200 dilution, Jackson ImmunoResearch 
Laboratories, Inc., West Grove, PA) in a humidified chamber for 1 h at 37 °C 
and washed in PBS similarly as before. Finally, sections were incubated with 
horseradish peroxidase-streptavidin (ABC Elite kit, Vector Laboratories) for 15 
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min at room temperature in a humid chamber and washed with PBS similarly 
as before. As the last staining step, 3,3'-diaminobenzidine (SIGMA FAST® 
DAB with Metal Enhancer, Sigma-Aldrich) was added to the sections and 
incubated at room temperature until a macroscopically appreciable light 
brown color developed inthe sections (generally 30 s to 5 min). After 
incubation with DAB, sections were lightly counterstained will Gill's 
hematoxylin. Histological examination and digital photography were carried 
out as described previously. 
Transmission electron microscopy
Samples were fixed in 2.5% glutaraldehyde in 0.1 M Sorensen’s buffer, pH 7.4, 
overnight at 4°C. After several rinses with buffer, they were postfixed in 1% 
osmium tetroxide in the same buffer. They were then rinsed in double distilled 
water to remove phosphate salt and then stained with aqueous 3% uranyl 
acetate for one hour. The samples were dehydrated in ascending 
concentrations of ethanol, rinsed two times in propolynoxide, and embedded 
in epoxy resin. They were ultra-thin sectioned at 70 nm in thickness and 
stained with uranyl acetate and lead citrate. The sections were examined using 
a Philips CM100 electron microscope at 60 kV. Images were recorded digitally 
using an Hamamatsu ORCA-HR digital camera system operated using AMT 
software (Advanced Microscopy Techniques Corp., Danvers, MA).
In situ detection of apoptosis
Paraffin-embedded embryo sections (6 μm) were deparaffinized, incubated in 
methanol containing 0.3% H2O2 for 30 min, washed, and incubated with 
proteinase K (20 μg/ml) in PBS for 15 min at room temperature. Apoptotic 
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cells were detected as described in the ApopTag Peroxidase In Situ Apoptosis 
Detection Kit (Millipore, Billerica, MA). Sections were counterstained with 
methyl green.
Cerebellar primary culture
Postnatal pups were killed by decapitation at P0 age. Cerebella were dissected, 
freed of meninges, collected in calcium and magnesium-free phosphate-
buffered saline (CMF-PBS, pH7.4). Cerebella were further digested with 
trypsin (1%; Invitrogen Corp.) in CMF-PBS for 3 min at room temperature. 
Tissue was then triturated sequentially with fire-polished Pasteur pipettes in 
CMF-PBS supplemented with 0.05% DNAase I (Invitrogen Corp.) and 12 mM 
MgSO4, to yield a single-cell suspension. Cells were spun down at 3,000g for 5 
min and resuspended in Neurobasal media (Invitrogen Corp.) supplemented 
with B-27, Glutamax-1 (Gibco Corp.), penicillin-streptomycin, and 10% horse 
serum. Cell were plated at a density of 11 x 105 cells per cm2 on 12 mm 
diameter poly-L-lysine (20 μg/ml) precoated glass coverslips for 1 h at 37 °C 
with 100% humidity and 5% CO2. After cells had attached (3-5 h), the medium 
was changed into Serum-Free Neurobasal medium. Cultures were maintained 
at 37 °C with 100% humidity and 5% CO2 for another 7 days.
Immunofluorescence and Nuclear Staining
The cerebellar neuronal cells were grown on glass coverslips in 24-well plates 
for 7 days. After 7 days, the cells were fixed with 4% paraformaldehyde at 
room temperature for 20 min, and permeabilized for 15 min by PBS containing 
0.3% Triton X-100. For calbindin staining, the cells were incubated with 
monoclonal anti-calbindin (1:200 dilution in PBS) for 1 h at room temperature. 
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After washed in PBS, the cells were incubated with fluorescein isothiocyanate-
conjugated secondary antibody for 1 h. For nuclear staining, the cells were 
incubated with 0.5 mg/ml Hoechst 33258 (Sigma) for 10 min at room 
temperature. Preparations were then washed in PBS, mounted in anti-fading 
solution (20 mM n-propyl gallate in 80% glycerol), and analyzed by an 
immunofluorescent microscopy (Olympus).
2.3 Results
2.3.1 Ablation of FIP200 in the neuronal precursors leads to severe 
neurological defects in mice
 To study potential role of FIP200 in the central nervous system, the 
floxed FIP200 (FIP200flox/flox) mice, in which exons 4 and 5 of FIP200 gene are 
flanked by two loxP sequences (Gan et al., 2006), were crossed with the nestin-
Cre transgenic mice which express Cre recombinase in neural precursors from 
E10.5 (Bates et al., 1999; Dahlstrand et al., 1995; Frappart et al., 2007). Cre-
mediated deletion of exons 4 and 5 leads to a frame-shift mutation because of 
direct splicing from exon 3 (containing ATG codon) to exon 6, producing a 
small truncated and nonfunctional peptide. In contrast to embryonic lethality 
of total KO of FIP200 (Gan et al., 2006), FIP200flox/flox; nestin-Cre (designated as 
Nestin-CKO) mice were born at the expected Mendelian ratio. However, 
approximately 45% of the mutant mice died shortly after birth within the first 
few days. The remaining mice also showed a significantly reduced survival 
rate after P14 and all mutant mice died by 60 days (Figure 2.1). The mutant 
mice showed growth retardation as compared to the control littermates 
starting from P7. By P21, the average weight and length of the mutant mice 
reached only about 50% and 75%, respectively, of the control mice (Figure 2.2).
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Figure 2.1 | Conditional  ablation of FIP200 by nestin-Cre causes early death. 
Conditional ablation of FIP200 by nestin-Cre causes early death, growth 
retardation and cerebellar ataxia. Kaplan-Meier survival curve of control and 
Nestin-CKO mice (n=53).
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Figure 2.2 | Conditional  ablation of FIP200 by nestin-Cre causes growth 
retardation. Body weight (top) and length (bottom) of control and Nestin-
CKO mice at various days after birth.
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Moreover, the mutant mice exhibited deficits in motor coordination starting 
around P14, which progressed to a severer extent with tremors, hyperactivity, 
and stiffness with movement. When they were suspended by their tails, the 
mutant mice showed the hind-limb crosses phenotype, whereas the control 
mice had the normally extended limbs (Figure 2.3). Consistent with the ataxia 
phenotype, histological analysis of the cerebella showed a smaller size for the 
mutant mice compared to the controls (Figure 2.4, panel A). The reduced 
cerebellum size is not a consequence of the smaller body size as the total size 
of the brain of the mutant mice was comparable to the controls (Figure 2.4, 
panel B). The foliation and fissuration appeared to be slightly less developed 
and the granule cell layer was thinner in the mutant cerebellum compared to 
the controls.
 To evaluate the depletion of FIP200 in the mutant mice, lysates prepared 
from various regions of the brain of the mutant and control mice were 
subjected to Western blotting analysis. Figure 2.5 shows that FIP200 was 
deleted efficiently in several regions of the mutant brain including cerebral 
cortex, hypothalamus, midbrain, medulla and cerebellum. Because of the 
severe ataxia phenotype of the Nestin-CKO mice, I focused my analysis on 
cerebellum and further examined FIP200 expression by 
immunohistochemistry. As shown in Figure 2.6, FIP200 was eminently 
expressed in Purkinje cells, some cells in the granular layer, and deep 
cerebellar nuclei in the white matter of the control mice. In contrast, FIP200 
was not detected in these cells of Nestin-CKO mice, confirming inactivation of 
FIP200 in the cerebella of the mutant mice. Together, these results suggest that 
deletion of FIP200 by nestin-Cre led to the development of cerebellar ataxia in 
mice.
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Figure 2.3 | Conditional  ablation of FIP200 by nestin-Cre causes ataxia. 
Control mice (left) extend their hind limbs and bodies, whereas Nestin- CKO 
mice (right) show abnormal limb-clasping reflexes by crossing their limbs, 
when suspended by tail. Scale bar=1 cm.
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Figure 2.4 | Conditional ablation of FIP200 by nestin-Cre causes cerebellar 
degeneration. (A) Histological analysis of sagittal sections of cerebellum from 
control and Nestin-CKO mice at P28. Note the slightly smaller cerebellum and 
thinner granule cell layer in CKO mice. Scale bar=1 mm. (B) Brain weight of 
control and Nestin-CKO mice at various days after birth.
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Figure 2.5 | Deletion of FIP200 in cerebellum analyzed by Western. Lysates 
were prepared from cerebral cortex (CC), hypothalamus (HT), midbrain (MB), 
medulla (M) and cerebellum (CB) of control or Nestin-CKO mice at P0 and 
then analyzed by Western blotting using anti-FIP200 (upper) or anti-vinculin 
(lower) antibodies.
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Figure 2.6 | Deletion of FIP200 in Nestin-CKO cerebellum analyzed by 
immunohistochemistry. Cerebella harvested from control (a and c) or Nestin-
CKO (b and d) mice at P14 were sectioned and analyzed by 
immunohistochemistry with anti-FIP200. FIP200 is detected in the deep cell 
nuclei (a) and Purkinje cells (c) in the control (arrows), but not Nestin-CKO 
cerebellum (b and d). Scale bars=200 μm (a and b) and 100 μm (c and d), 
respectively.
2.3.2 Deletion of FIP200 results in progressive loss of Purkinje cells, 
spongiform and neurite degeneration in the cerebellum
 To study the cerebellum defects in Nestin-CKO mice, histological 
analyses were performed on cerebella of the control and mutant mice at 
various stages of postnatal development. At P7 (data not shown) and P14 
(Figure 2.7 panel a and b), the cellular organization of the cerebella was 
comparable between the Nestin-CKO and control mice although the external 
granular layer (EGL) appeared slightly thinner in the mutant mice. After P14, 
Nestin-CKO mice showed a progressive loss of Purkinje cells and the 
interneurons in the molecular layer as well as a gradual decrease in the 
thickness of the molecular layer relative to those in the control mice. 
Furthermore, signs of spongiform degeneration were observed in the white 
matter of the mutant mice at P14, which progressed to a very significant level 
at P56 (arrows, Figure 2.8 panel f). At P56, I also observed severe spongiform 
degeneration in the molecular layer and a slight decrease in the granule cells 
of the mutant cerebellum (Figure 2.7 panel f).
 To further determine defects of Purkinje cells in the mutant mice, 
cerebellum sections were analyzed by immunohistochemistry using antibody 
against calbindin, a marker for Purkinje cells. Consistent with histological 
analysis, Figure 2.9 shows a decreased number of Purkinje cells in Nestin-
CKO mice compared to the control mice (Figure 2.9 a and b). The staining also 
revealed extensive degeneration of dendrites in the mutant mice (Figure 2.9 
compare panels a and b). Furthermore, calbindin labels were also found on 
particles that are slightly smaller than Purkinje cells in the granular layer 
(arrows), which could be segments of swelling (degenerating and/or 
abnormal) axons from the Purkinje cells traversing the granular layer. 
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Figure 2.7 | Deletion of FIP200 in cerebellum leads to progressive loss of 
Purkinje cells and spongiform degeneration in Nestin-CKO mice. Cerebellar 
sections from control (a, c, e) and Nestin-CKO (b, d, f) mice at different ages 
were stained by H&E. External granular layer (EGL), molecular layer (ML), 
Purkinje cell layer (PCL) and internal granular layer (GL) are marked on the 
left. Insets show high magnification view of bracketed areas in e and f. Arrows 
mark spongiform degeneration in the molecular layer. Scale bars=100 μm.
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Figure 2.8 | Deletion of FIP200 in cerebellum leads to progressive 
development of spongiform degeneration in Nestin-CKO mice. Cerebellar 
sections from control (a, c, e) and Nestin-CKO (b, d, f) mice at different ages 
were stained by H&E. Arrows mark spongiform degeneration in the white 
matter. Scale bar=200 μm.
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Figure 2.9 | Purkinje cell degeneration in cerebellum of Nestin-CKO mice.
Cerebellum sections from 6-week-old control and Nestin-CKO mice were 
analyzed by immunohistochemistry with anti-calbindin. Note the loss of 
Purkinje cells in the Purkinje cell layer and degeneration of their dendrites (b) 
and axons (d) in cerebellum from Nestin-CKO mice compared to control mice. 
Arrows in panel b mark abnormal staining with anti-calbindin in the granular 
layer of the mutant mice. Scale bars=200 μm.
Examination of the white matter indicated extensive axonal degeneration 
associated with swelling regions of the labeled axons as well as vacuoles 
typical of spongiform degeneration as detected by H/E staining (see Figure 
2.7) in the mutant mice (Figure 2.9 panels c and d).
 I next examined myelination in the white matter of the mutant mice 
because nestin-Cre is active in glial cells and potential defects in 
oligodendrocytes and myelination could also contribute to the cerebellum 
ataxia defects in Nestin-CKO mice (Fraser et al., 2008). Cerebellar sections 
prepared from 4-week-old Nestin-CKO and control mice were analyzed by 
immunohistochemistry using antibody against myelin basic protein (anti-
MBP). Extensive labeling with anti-MBP was found in the white matter of 
Nestin-CKO as well as control mice, suggesting that myelination was not 
significantly affected in the mutant mice (Figure 2.10 panels a and b). Staining 
of the sections with anti-olig2 (marker for oligodendrocytes) showed no 
significant distinction in the number of oligodendrocytes in Nestin-CKO and 
control mice (data not shown). Thus, axonal degeneration of Purkinje cells is 
unlikely a secondary consequence caused by deficiency of myelination in the 
mutant mice.
 Analogous to H/E and calbindin staining of the white matter (Figure 2.8 
and 2.9), significant spongiform degeneration was also evident by anti-MBP 
staining. Interestingly, the vacuoles appear to be embedded in the circle of 
MBP staining (Figure 2.10 b), suggesting these vacuoles may result from the 
degeneration of Purkinje cell axons encircled with myelin. The vacuoles are 
negative by Oil red O staining for lipids or periodic acid-Schiff (PAS) staining 
for polysaccharides (data not shown). The samples were then further 
examined by transmission electron microscopy of sections of white matter of 
115
116
Figure 2.10 | Axon degeneration in cerebellum of Nestin-CKO mice. 
Cerebellum sections from 4-week-old control and Nestin-CKO mice were 
analyzed by immunohistochemistry with anti-MBP (panels a and b) or by 
transmission electron microscopy (panels c and d). Note that the vacuoles are 
embedded in myelin-sheath (arrows in b and d) of the mutant mice. Scale 
bars=50 μm (a and b) and 1 μm (c and d), respectively.
the mutant and control mice (Figure 2.10 panels c and d). Consistent with anti-
MBP staining, apparently normal myelination was found in the mutant mice 
as well as control mice. However, the axon bundles in the mutant mice were 
more rounded compared to the irregular shape of that in the control mice, 
possibly as a consequence of swelling in some segments of the axons. 
Furthermore, some of the ensheathments did not contain axon fibers (arrow) 
in the mutant mice. These results are consistent with the MBP staining of the 
sections (see Figure 2.10 panels a and b) and provide further support for 
extensive swelling and degeneration of Purkinje cell axons, which may be 
responsible for the spongiform degeneration observed in the white matter of 
Nestin-CKO mice. Consistent with the extensive neural degeneration, 
immunostaining with antibody against GFAP showed significant reactive 
gliosis in the mutant cerebellum (Figure 2.11). Together, these studies 
suggested that reduced Purkinje cells and degeneration of their axons and 
dendrites are likely to be responsible for the loss of normal cerebellum 
functions in the motor coordination of Nestin-CKO mice.
 
2.3.3 Increased apoptosis and accumulation of ubiquitinated protein 
aggregates upon FIP200 deletion
 To explore potential mechanisms by which deletion of FIP200 leads to 
neurodegeneration, I examined possible increases in apoptosis and 
ubiquitinated protein aggregates in the cerebellum of the mutant mice as 
many neurodegenerative diseases are associated with accumulation of 
ubiquitinated protein aggregates and loss of neurons resulting from apoptosis 
(Gao and Hu, 2008; Layfield et al., 2005; Rubinsztein, 2006). Previous studies 
showed that deletion of FIP200 resulted in increased apoptosis in the 
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Figure 2.11 | Reactive gliosis in cerebellum of Nestin-CKO mice. 
Cerebellum sections from 6-week-old control and Nestin-CKO mice were 
analyzed by immunohistochemistry with anti-GFAP. Scale bar=200 μm.
developing heart and liver leading to major defects in these organs and 
embryonic lethality of KO mice (Gan et al., 2006). The observation of reactive 
gliosis also suggested the neuronal injury in the cerebellum in Nestin-CKO 
mice. I therefore examined whether an increased apoptosis may account for 
the reduced neurons in the Nestin-CKO mice by TUNEL assays of cerebella 
from the mutant and control mice at different postnatal days. Figure 2.12 
shows that apoptosis was observed in the cerebella of control mice during the 
first 2 weeks of postnatal development as expected (Altman, 1972a; Altman, 
1972b), but the mutant mice showed an increase in apoptosis compared to the 
controls at these times. As expected, the normal developmental apoptosis in 
the control mice reduced to a minimal level concomitant with the completion 
of postnatal development of the cerebellum at 3 weeks after birth. In contrast, 
significant levels of apoptosis were found in the mutant cerebella at 3 weeks 
and later after birth. These results suggest that depletion of FIP200 in the 
neurons could lead to increased apoptosis leading to neural degeneration in 
the mutant cerebellum.
 I next examined the potential accumulation of ubiquitinated protein 
aggregates by staining of cerebellum sections from Nestin-CKO and control 
mice were with the anti-ubiquitin antibody. While no sign of ubiquitin 
aggregation was detected in the control cerebellum, large ubiquitin-positive 
aggregates were found in the white matter (Figure 2.13 panel a and b; arrows) 
and Purkinje cells (Figure 2.13 panel e; arrows) in the mutant cerebellum. 
Moreover when samples of Nestin-CKO cerebella were compared their 
immunoactivity of ubiquitin between different ages (Figure 2.13 panel c and d) 
I found that the small protein aggregates at P0 became the larger ones at P42,
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Figure 2.12 | Increased apoptosis in cerebellum of Nestin-CKO mice. 
Cerebellum sections from control or Nestin-CKO mice at various postnatal 
days were analyzed by TUNEL assays. The number of apoptotic cells were 
determined and the mean ± s.e. from three experiments is shown.
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Figure 2.13 |Ubiquitinated protein aggregates in cerebellum of Nestin-CKO 
mice. Cerebellum sections from control or Nestin-CKO mice were analyzed by 
immunohistochemistry using anti-ubiquitin. Arrows marks the aggregates of 
ubiquitinated proteins. Note the ubiquitin-positive aggregates in the white 
matter at P42 (b) and in the Purkinje cells at P14 (e). The ubiquitinated protein 
aggregates progressively accumulated during aging (compare panels c at P0, 
and d at P42). Scale bars=200 μm (a and b) and 50 μm (c, d,and e), respectively.
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indicating that deletion of FIP200 resulted in abnormal progressive 
accumulation of ubiquitinated protein aggregates.
2.3.4 Deletion of FIP200 in the Purkinje cells led to axonopathy
 From the previous immunohistochemistry stainings against calbindin, 
results have shown that the Purkinje cells in the Nestin-CKO cerebellum 
exhibit abnormal morphology, such as dendrite degeneration and axon 
swelling. To examine whether ablation of FIP200 causes axonopathy of the 
Purkine cells, the whole cerebellar cells from the Nestin-CKO or their control 
littermates was prepared and cultured in neuron-specific media for 7 days. In 
vitro neuronal cell cultures primarily contain two types of neurons, granule 
cells and Purkinje cells. After they were cultured 7 days in vitro, the Purkinje 
cells were fixed, analyzed by immunofluorescent using anti-calbindin, and 
observed the morphology by microscopy. As seen in Figure 2.14 (panel A), the 
Purkinje cells from the control mice grew, extended, and branched their thin 
axons to form synapses with other neuronal cells in the cell culture. In 
contrast, the Purkinje cells with FIP200-deletion exhibited axonopathy, 
including reduced axon outgrowth and numerous swollen segments of axon 
(Figure 2.14A and 2.15). The quantitative data showed the axonal outgrowth of 
the Purkinje cells from Nestin-CKO was significantly reduced approximately 
60% as compared to their control cells (Figure 2.14, panel B). The in vitro 
results of axonophathy on the Purkinje cells were consistent with my in vivo 
findings by using immunohistochemistry against calbindin. These in vitro and 
in vivo results both suggested that ablation of FIP200 led to abnormal 
morphology of the Purkinje cells.
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Figure 2.14 | Reduced axon outgrowth of the Nestin-CKO Purkinje cell. (A) 
In vitro Purkinje cells from control or Nestin-CKO mice at 7 days were 
analyzed by immunofluorecent using anti-calbindin. (B) The axon length of 
the Purkinje cells were determined and the mean ± s.e. from three experiments 
is shown (cell number=25). Scale Bar=100 μm.
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Figure 2.15 |Axonopathy of the Purkinje cell from the cerebellum of Nestin-
CKO mice. In vitro Purkinje cells from control or Nestin-CKO mice at 7 days 
were analyzed by immunofluorecent using anti-calbindin and Hoechst 33258. 
Note arrows mark the swelling segment of axon. Scale Bars=100 μm.
2.4 Discussion
 Work in the last decades has significantly advanced the understanding of 
the genetic   basis of various neurodegenerative diseases by identifying 
mutations of genes in the diseases as  well as the conceptualization that the 
accumulation of abnormal protein aggregation may be the   underlying 
common mechanism of these diseases. Particularly, protein quality 
control   mechanisms including the ubiquitin-proteasome system and 
autophagy have been suggested to play  crucial roles in the homeostasis of 
neurons and neurodegeneration (Giobbe et al., 1991; Winslow and 
Rubinsztein, 2008). However, the   molecular components and signaling 
pathways that regulate these cellular processes in various neurodegenerative 
diseases are still not well understood at present.
 By using a neural-specific conditional KO approach, I identified FIP200 
as an important regulatory protein in CNS for neuronal homeostasis. Deletion 
of FIP200 resulted in abnormal accumulation of   ubiquitinated protein 
aggregates, axonal swelling, increased apoptosis and loss of Purkinje 
cells, spongiform degeneration in the cerebellum, which are associated  with 
cerebellar degeneration and   ataxia in mice. My studies showed that the 
mutant mice with conditional FIP200 deletion share several phenotypes as the 
recently reported Atg5 or Atg7 conditional KO mice by nestin-Cre (Hara et al., 
2006; Komatsu et al., 2006), such as the increased ubiquitin aggregates, 
progressive loss of the Purkinje cells, increased apoptosis in the cerebellum, 
cerebellar ataxia, and early death of the mice.  However, whether FIP200 is 
involved in the regulation of autophagy remains obscure presently. 
 Interestingly, a recent study identified an interaction between FIP200 and 
ULK1, mammalian homolog of yeast Atg1, and showed that   FIP200 is 
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required for both mTOR-dependent and –independent autophagy in 
mammalian cells in vitro (Hara et al., 2008). Thus, the data presented here 
strongly suggest a role of FIP200 in the regulation of autophagy in vivo and 
deficiency in autophagy upon FIP200 inactivation is likely a major contributor 
to the neurodegeneration in the mutant mice. Although ULK1 has been shown 
to be mammalian ortholog of yeast Atg1 in the Atg1/Atg13/Atg17 complex 
critical for autophagosome initiation, the mammalian homologs for the other 
two components have not been characterized. Aside from the previous report 
on FIP200 interaction with ULK1, studies have shown that a recent identified 
mammalian ortholog of Atg13 interacts with both ULK1 and FIP200 in a high 
molecular weight complex (Ganley et al., 2009; Hosokawa et al., 2009; Jung et 
al., 2009). With these in vitro data, they provide further support for the idea 
that FIP200 is likely a mammalian functional counterpart of Atg17 despite 
limited   homology in their protein sequences (Hara and Mizushima, 
2009). While they share many phenotypes with Atg5 or Atg7 conditional KO, 
FIP200 conditional KO mice developed many defects such as loss of Purkinje 
cells as well as movement disorders at an earlier age. As ULK1-Atg13-FIP200 
complex is required for autophagosome initiation whereas Atg5 and Atg7 are 
involved in the later steps of autophagy (Hara et al., 2006; Komatsu et al., 
2006), it is possible that these differences reflect the temporal requirements for 
autophagy to remove abnormal protein aggregates that were responsible for 
the various neural degeneration phenotypes. On the other hand, FIP200 has 
been shown to regulate several other signaling pathways and   cellular 
processes besides its interaction with ULK1 and regulation of autophagy 
(Hara et al., 2008). It is therefore possible that perturbations of other signaling 
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pathways may contribute to the earlier and maybe severer phenotypes in the 
FIP200 conditional KO mice.
 My studies also revealed several distinctive features of neural-specific 
FIP200   conditional KO mice including the progressive development of 
spongiform degeneration that   were not observed in the Atg5 or Atg7 
conditional KO mice (Hara et al., 2006; Komatsu et al., 2006). Signs of 
spongiform degeneration in the white matter were found as early as 2 weeks 
of age in Nestin-CKO mice and precede the loss of Purkinje cells in the mutant 
mice. Furthermore, I also observed the swelling of segments of Purkinje cell 
axons both in vivo (see Figure 2.9) and in vitro (see Figure 2.15). The blockages 
in axonal transport resulting from defects in microtubule based motors has 
been proposed to be responsible for the axonal swelling phenotype (Bendiske 
and Bahr, 2003; Stokin et al., 2005). Thus, it is possible that ablation of 
FIP200 could induce the neuronal defects because of abnormality in the axonal 
transport machinery in Purkinje cells, independent of (or in combination with) 
the potential autophagy defects discussed above. Alternatively, such blockages 
could be caused by the progressive accumulation of  ubiquitinated protein 
aggregates (instead of the transport machinery itself) upon FIP200 deletion but 
not (or not as severe) in Atg5- or Atg7-deficient neurons. In this regard, it 
is interesting to note that the aggregation of ubiquitinated proteins was first 
observed in the white  matter correlated with the early signs of spongiform 
degeneration and anterior to any apparent loss of Purkinje cells. Therefore, the 
progressive degeneration of Purkinje cell axons  may be responsible for the 
dysfunction of these neurons and their death.
 Spongiform degeneration is caused by extensive vacuolization of 
neuronal cells, which are typically associated with brain damage induced by 
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Prions (Hooper, 2003). The underlying mechanism of such vacuolization is not 
well understood but mitochondrial dysfunction and increased reactive oxygen 
species (ROS) production and/or sensitive to ROS have been suggested to be 
responsible for spongiform degeneration in several disease models 
(Akassoglou et al., 2004; Li et al., 1995; Lin et al., 2004; Matalon et al., 2000; 
Puccio et al., 2001). Interestingly, several other mice KO models of 
neurodegenerative diseases such as those  with deletions in mitochondrial 
protein, Sod1 (Li et al., 1995) or PGC1-α (Lin et al., 2004), also showed 
spongiform degeneration   as prominent features of the neurodegeneration 
phenotype. It will be interesting to   determine potential abnormalities in 
mitochondria as well as ROS production and/or sensitivity upon deletion of 
FIP200 in neurons or other cell types, which may or may not be caused 
by  abnormal accumulation of ubiquitinated protein aggregates.  The above 
considerations suggest that deletion of FIP200 in neurons could induce 
axon   swelling and/or spongiform degeneration because of deficiencies in 
other signaling pathways rather   than (or in combination with) defects in 
autophagy that are present in Atg5 or Atg7 conditional KO mice.
 Consistent with this possibility, previous studies showed that total KO of 
FIP200  caused embryonic lethality resulting from defective heart and liver 
development as a result of defective  TNFα-JNK and TSC-mTOR signaling 
pathways (Gan et al., 2006), whereas Atg5-/- and Atg7-/- mice were  born at 
normal Mendalian ratio and dies only shortly after birth because of deficiency 
in autophagy (Hara et al., 2006; Komatsu et al., 2006). It is interesting to note 
that both FIP200 KO MEFs and liver cells have shown increased sensitivity to 
TNFα-induced cell death compared to the control cells (Gan et al., 2006). 
Although a reduction  in JNK-mediated survival signaling was shown to be 
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responsible for the increased apoptosis in these cells upon TNFα treatment, it 
is known that TNFα stimulation also induces production of ROS which could 
play a role in cell survival and death. Thus, it is conceivable that an 
abnormality in  ROS production and/or sensitivity in neuronal cells upon 
FIP200 could contribute to the axonal   swelling leading to spongiform 
degeneration in the mutant mice. mTOR signaling pathways have also been 
implicated in the regulation neurodegeneration, neuronal cell survival, and 
axonal  development (Jaworski and Sheng, 2006). Consistent with previous 
studies in cells and embryos (Gan et al., 2006), reduced mTOR activity were 
found in Purkinje cells of Nestin-CKO mice (data not shown), which 
could  contribute to defects not seen in Atg5 or Atg7 conditional KO mice 
resulting from autophagy deficiency. Future studies will be required to resolve 
the potential contributions of these and possibly other signaling pathways in 
mediating neurodegenerative defects in FIP200 conditional KO mice.
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Chapter 3
NEURAL SPECIFIC DELETION of FIP200 LEADS to 
CEREBELLAR DEGENERATION THROUGH DEFECTIVE 
AUTOPHAGY AND 
ALTERED TNFR-1 SIGNALING PATHWAY 
3.1 Introduction
 Damages to the cerebellum caused by either injury or neurodegeneration 
are associated with ataxia both in humans as well as mouse models 
(Goldowitz and Hamre, 1998; Sillitoe and Joyner, 2007; Wang and Zoghbi, 
2001). Previous studies have identified various gene mutations underlying the 
different neurodegenerative disorders and revealed the accumulation of 
abnormal protein aggregation as a potentially common cellular mechanism of 
these diseases. However, our understanding of the molecular and cellular 
mechanisms by which key signaling molecules and pathways regulate these 
cellular processes in neurodegeneration is still incomplete. FIP200 is an 
evolutionarily conserved 200 kDa protein characterized by a large coiled-coil 
region (Chano et al., 2002b; Ueda et al., 2000). Initially identified as a protein 
that interacts with and inhibits the kinases Pyk2 and FAK (Ueda et al., 2000), 
FIP200 also associates with other cellular proteins and regulates several 
signaling pathways (Gan and Guan, 2008).
 Autophagy is an evolutionarily conserved cellular process from yeast to 
man (Cuervo, 2004; Levine and Klionsky, 2004; Mizushima, 2007; Mizushima 
and Klionsky, 2007; Mizushima et al., 2008; Rubinsztein, 2006), that  plays 
essential roles in the removal of proteins with aberrant structures to maintain 
cellular homeostasis, which is particularly important in post-mitotic cells such 
as neurons. Genetic  studies using yeast as a model system have identified 
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thirty-one autophagy-related ATG genes and defined the complex formations 
of the Atg proteins and their functions (Klionsky, 2005; Suzuki and Ohsumi, 
2007). Mammalian  orthologs for some of the yeast Atg proteins have been 
identified and characterized to play crucial roles in autophagy in development 
and diseases processes such as cancer and neurodegeneration (Hippert et al., 
2006; Winslow and Rubinsztein, 2008). Aside from the recent findings 
suggesting a role of FIP200 in autophagosome initiation as a key component of 
the ULK1-Atg13-FIP200 complex in fibroblasts (Ganley et al., 2009; Hosokawa 
et al., 2009; Jung et al., 2009), RNAi-mediated knockdown of FIP200 has been 
shown to cause neurite atrophy and apoptosis in a neuroblastoma cell line 
Neuro-2a (Chano et al., 2007; Chano et al., 2006). However, it remains 
unknown about the potential role and mechanisms of FIP200 regulation of 
autophagy and homeostasis of neurons in vivo. Although the primary function 
of autophagy is the supply of amino acids as a response to starvation 
conditions in many organisms, basal autophagy, independent of nutrient 
stress, also has been suggested that it plays an important role in maintaining 
cellular homeostasis, particularly in quiescent cells such as neurons. FIP200 
was recently proposed as a mammalian counterpart of yeast Atg17 
(autophagy-related 17) required for autophagosome initiation despite its 
different structure and sequence from Atg17 (Hara and Mizushima, 2009). 
 To study whether mammalian FIP200 regulates autophagy in vivo and 
whether its regulation of autophagosome initiation or other signaling 
pathways is involved in neuronal homeostasis and neurodegeneration, I 
generated transgenic mice with conditional deletion of FIP200 using nestin-
Cre, hGFAP-Cre and L7-Cre with complementary Cre expression in the 
cerebellum provided support for a Purkinje cell-autonomous function of 
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FIP200 in the regulation of cerebellar degeneration. Consistent with a role of 
FIP200 in autophagy, I observed progressive accumulation of abnormal 
ubiquitinated protein aggregates without any impairment of the ubiquitin-
proteasome activity, increased apoptosis, and mitochondrial damage in 
Purkinje cells of mutant mice. Lastly, I found that deletion of TNFR-1 rescued 
both the loss of Purkinje cells and spongiform degeneration in FIP200 
conditional KO mice. Together, these results provide compelling genetic 
evidence that FIP200 regulation of autophagy and TNFR-1 signaling plays 
critical roles in the pathogenesis of neurodegenerative disorders in mammals.
3.2 Material and Methods
Animals and genotyping
FIP200flox/flox mice were described previously (Gan et al., 2006). Nestin-Cre 
(Tronche et al., 1999), hGFAP-Cre (Zhuo et al., 2001), L7-Cre (Smeyne et al., 
1995) and TNFR-1 (Pfeffer et al., 1993) transgenic mice were obtained from The 
Jackson Laboratory (Bar Harbor, ME). p53flox/flox transgenic mice (Jonkers et al., 
2001) were kind gifts from Dr. Alexander Nikitin (Cornell University). Mice 
were housed and handled according to local, state, and federal regulations, 
and all experimental procedures were carried out according to the guidelines 
of Institutional Animal Care and Use Committee at Cornell University and the 
University of Michigan. Mice genotyping for FIP200 and Cre alleles were 
performed by PCR analysis of tail DNA, essentially as described previously 
(Gan et al., 2006; Wei et al., 2009).
Histology and Immunohistochemistry
Mice were euthanized using CO2, and a complete tissue set was harvested
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during necropsy. Fixation was carried out for 16 h at 4°C using freshly made, 
pre-chilled (4°C) PBS-buffered formalin. The brain tissues were all sagittal 
sectioned and then embedded in paraffin, sectioned at 6 μm, and stained with 
hematoxylin and eosin for routine histological examination or left unstained 
for immunohistochemistry. Hematoxylin- and eosin-stained sections were 
examined under an Olympus BX41 light microscope (Olympus America, Inc., 
Center Valley, PA), and images were captured with an Olympus digital camera 
(model DP70) using a DP Controller software (Version 1.2.1.10 [EC] 8). For 
immunohistochemistry, unstained tissue sections were first deparaffinized in 3 
washes of xylene (3 min each) and were rehydrated in graded ethanol 
solutions (100, 95, 70, 50, and 30%). After heat-activated antigen retrieval 
(model Retriever 2000, PickCellLaboratories B.V., Amsterdam, Holland) 
according to manufacturer's specifications, sections were treated with blocking 
solutions; first with Avidin-Biotin Block (Dako Corp., Carpinteria, CA) then 
with Protein Block Serum Free (Dako Corp.). Sections were then incubated 
with the primary antibody (calbindin 1:2000, Sigma-Aldrich; ubiquitin 1:500, 
Cell signaling; Dako corp.; cytochrome c 1:100 BD) at 37 °C for 1 h in a humid 
chamber, washed in PBS 3 times (5 min each), then incubated with the 
biotinylated secondary antibody anti-mouse for calbindin, ubiquitin, and 
cytochrome c (1:200 dilution, Jackson ImmunoResearch Laboratories, Inc., 
West Grove, PA) in a humidified chamber for 1 h at 37 °C and washed in PBS 
similarly as before. Finally, sections were incubated with horseradish 
peroxidase-streptavidin (ABC Elite kit, Vector Laboratories) for 15 min at room 
temperature in a humid chamber and washed with PBS similarly as before. As 
the last staining step, 3,3'-diaminobenzidine (SIGMA FAST® DAB with Metal 
Enhancer, Sigma-Aldrich) was added to the sections and incubated at room 
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temperature until a macroscopically appreciable light brown color developed 
inthe sections (generally 30 s to 5 min). After incubation with DAB, sections 
were lightly counterstained will Gill's hematoxylin. Histological examination 
and digital photography were carried out as described previously. 
Proteasomal catalytic activity assay
Proteasomal catalytic activity was analyzed for the lysates using the synthetic 
peptide substrates linked to the fluorometric receptor and 
aninomethylcoumarin (AMC) (Proteasome Substrate Pack from Biomol, 
Plymouth Meeting, PA). Mice cerebella were dissected, placed on ice and 
homogenized in proteolysis activity buffer (DTT 0.5 mM, ATP 5 mM, MgCl2 5 
mM). The 250 μl aliquots containing equal amounts of protein were incubated 
for 30 min at 37 °C with 2.5 μl of Ac-Gly-Pro-Leu-Asp-AMC (5 mM), Z-Leu-
Leu-Glu-AMC (5 mM), Suc-Leu-Leu-Val-Tyr-AMC (5 mM), Ac-Arg-Leu-Arg-
AMC (5 mM) or Boc-Leu-Arg-Arg-AMC (5 mM) for caspase-like, 
chymotrypsin or trypsin-like activity, respectively. The reaction was stopped 
by adding 252.5 μl ice-cold ethanol (96%). The Proteasomal catalytic activity 
was determined by measuring the increase of fluorescence from AMC 
hydrolysis (380 nm excitation and 460 nm emission).
Transmission electron microscopy
Samples were fixed in 2.5% glutaraldehyde in 0.1 M Sorensen’s buffer, pH 7.4, 
overnight at 4°C. After several rinses with buffer, they were postfixed in 1% 
osmium tetroxide in the same buffer. They were then rinsed in double distilled 
water to remove phosphate salt and then stained with aqueous 3% uranyl 
acetate for one hour. The samples were dehydrated in ascending 
141
concentrations of ethanol, rinsed two times in propolynoxide, and embedded 
in epoxy resin. They were ultra-thin sectioned at 70 nm in thickness and 
stained with uranyl acetate and lead citrate. The sections were examined using 
a Philips CM100 electron microscope at 60 kV. Images were recorded digitally 
using an Hamamatsu ORCA-HR digital camera system operated using AMT 
software (Advanced Microscopy Techniques Corp., Danvers, MA).
Rotarod test 
The Rotarod experiments were performed as described previously (McKinney 
and Murphy, 2006). Mice were placed on the rotating drum of an accelerating 
rotarod (Ugo Basile/Stoelting accelerating rotarod, Chicago, IL, USA). During 
a 5-min accelerating period of the rotarod speed from 4 to 40 rpm, the time for 
each mouse staying on top of the drum was recorded.
3.3 Results
3.3.1 Analysis of conditional KO of FIP200 in cerebellar neurons other than 
Purkinje cells using hGFAP-Cre
 As delineated in Chapter 2, nestin-Cre is active in the neural precursors 
which give rise to both cerebellar neurons and glial cells (Bates et al., 1999; 
Dahlstrand et al., 1995; Frappart et al., 2007), raising the possibility that 
deficiency in other neurons and/or glial cells of the cerebellum could also 
contribute to the ataxia phenotype either directly or indirectly by causing 
secondary degenerative defects of Purkinje cells (Baptista et al., 1994; 
Morrison and Mason, 1998). Although my analysis of Nestin-CKO mice 
showed apparently normal myelination (see Figure 2.10) as well as 
oligodendrocytes (data not shown), loss of granule cells and interneurons are 
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noted in these mice (see Figure 2.7). Therefore, to study a possible Purkinje 
cell-autonomous function of FIP200 in cerebellar degeneration and ataxia, I 
created FIP200 conditional KO mice using hGFAP-Cre mice (designated as 
hGFAP-CKO mice) which express Cre in cerebellar neurons as well as glial 
cells, but not in Purkinje cells (Zhuo et al., 2001). Consistent with the more 
restricted expression pattern of hGFAP-Cre compared to that of nestin-Cre, 
hGFAP-CKO mice were obtained at the expected Mendelian ratio. In contrast 
to the cerebellar ataxia phenotype starting at about 2 weeks of age and 
becoming very evident by 4 weeks as well as pre-mature lethality of Nestin-
CKO mice by   about 8 weeks of age (see Figure 2.1), hGFAP-CKO mice 
appeared healthy with apparently normal movements until at least 8 weeks of 
age. Histological examination of cerebellar sections prepared from hGFAP-
CKO mice at 4 weeks of age showed a reduced number of interneurons in the 
molecular layer and a slight decrease of granule cells in the mutant mice 
compared to the control mice (Figure 3.1, compare panels a and b). In contrast 
to Nestin-CKO mice (panel c), however, I did not observe any defects in 
Purkinje cells and their dendrites extending into the molecular layer (arrows) 
or the reduction in the thickness of the molecular layer in hGFAP-CKO mice at 
4 weeks of age (panel b). Staining of the sections with anti-calbindin showed 
apparently normal axons of Purkinje cells in hGFAP-CKO mice (Figure 3.2, 
compare panels a and b) in contrast to that in Nestin-CKO mice (panel c). 
These results are consistent with the lack of hGFAP-Cre expression in Purkinje 
cells and suggest that cerebellar degeneration and the ataxia phenotype 
observed in Nestin-CKO mice were caused by Purkinje cell-autonomous 
defects upon FIP200 deletion in these cells.
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Figure 3.1 | Cerebellum cortex in hGFAP-CKO mice. Cerebellar sections 
from control (a, d), hGFAP-CKO (b, e) and Nestin-CKO mice (c) at different 
ages were stained by H&E. Molecular layer (ML), Purkinje cell layer (PCL) 
and internal granular layer (GL) are marked on the left. Arrows (a and b) mark 
normal dendrites from Purkinje cells. Scale bars=100 μm.
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Figure 3.2 | Analysis of Purkinje cells in cerebellum of hGFAP-CKO mice. 
Cerebellar sections from control (a, d), hGFAP-CKO (b, e) and Nestin-CKO (e) 
mice at different ages were analyzed by immunohistochemistry with anti-
calbindin. Scale Bars=100 μm.
 Slight movement abnormality was observed for hGFAP-CKO mice 
compared to the littermate controls around 12 weeks of age and the phenotype 
of movement incoordination progressed to paralysis by about 20 weeks of age. 
Figure 3.3 shows the significant deficit in the motor coordination of hGFAP-
CKO mice compared to the control mice at 16 weeks of age as measured by 
Rota-Rod tests. Consistent with the neurological defects at the older age, 
histological analysis of cerebellum sections showed a decreased number of 
Purkinje cells and a slightly reduced thickness of the molecular layer in 
hGFAP-CKO mice when compared to control mice (Figure 3.1, panels d and e). 
Furthermore, calbindin staining confirmed the reduction of Purkinje cell 
numbers and revealed significant degenerations of Purkinje cell axons in 
hGFAP-CKO mice when compared to control mice (Figure 3.2, panels d and e). 
Because hGFAP-Cre is not expressed in Purkinje cells, degeneration of 
Purkinje cell axons was likely caused by the defective granule cells in the older 
hGFAP-CKO mice as previous studies suggested that abnormalities in granule 
cells and/or glial cells could lead to degeneration of Purkinje cells (Baptista et 
al., 1994; Morrison and Mason, 1998). These results are also consistent with the 
late-onset of the ataxia phenotype in these mice compared to Nestin-CKO 
mice and provide additional support for the critical role of Purkinje cells in 
cerebellar degeneration and ataxia of the mutant mice upon deletion of FIP200 
either directly (in Purkinje cells by nestin-Cre) or indirectly (in neurons other 
than Purkinje cells by hGFAP-Cre).
3.3.2 Ablation of   FIP200 leads to cell-autonomous degeneration of the 
Purkinje cells and cerebellar ataxia
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Figure 3.3 | Analysis of motor coordination in hGFAP-CKO mice. Control 
(n=4) or hGFAP-CKO (n=3) mice were placed on accelerating rotarods and 
latency to fall was recorded. The mean ± s.e. are shown.
 To complement the above studies and further validate the Purkinje cell-
autonomous defects in Nestin-CKO mice, I generated FIP200 conditional KO 
mice using L7-Cre mice which express Cre only in Purkinje cells (Lewis et al., 
2004; Smeyne et al., 1995). As expected, the FIP200flox/flox;L7-Cre (designated 
L7-CKO) mice were produced at Mendelian ratio and the mice were viable 
until at least 6 months of age. However, signs of ataxia were observed in the 
mutant mice by about 4 weeks of age. Measurement of motor coordination by 
Rota-Rod test showed a slight deficit in 4-week old mice, which progressed to 
a severer level by 8 weeks of age and beyond (Figure 3.4). I next examined the 
potential degeneration of Purkinje cells and their neurites by staining of the 
cerebellar sections with anti-calbindin (Figure 3.5). At 4 weeks of age, the 
number of Purkinje cells as well as their dendrites (Figure 3.5, panel a) and 
axons in the white matter (Figure 3.5, panel b) in the L7-CKO mice were 
comparable to those in the control mice (data not shown). However, calbindin 
staining revealed swelling segments of Purkinje cell axons (arrows), indicating 
their degeneration in L7-CKO mice. In addition, spongiform degeneration was 
observed in the white matter of L7-CKO mice (Figure 3.9, panel c). At 8 weeks 
of age, a significant loss of Purkinje cells and signs of degeneration of 
dendrites was observed in the mutant mice (Figure 3.5, panel c). Furthermore, 
more axonal swelling (arrows, Figure 3.5, panel c) and a reduced density of 
axons in the white matter (Figure 3.5, panel d) were found for the mutant mice 
compared to that at 4 weeks.
 At 16 weeks of age, few Purkinje cells were left (Figure 3.5, panel e), a 
further degeneration of dendrites and axons as well as increased size of the 
axonal swelling (Figure 3.5, panels e and f) were observed for the mutant mice. 
Lastly, similar to Nestin-CKO mice, extensively abnormal ubiquitinated
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Figure 3.4 | Movement ataxia in L7-CKO mice. Control (n=5) or L7-CKO 
(n=5) mice at different ages were placed on accelerating rotarods and latency 
to fall were recorded. Note that data were normalized to control. The mean ± 
s.e. are shown.
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Figure 3.5 | Degeneration of Purkinje cells in L7-CKO mice. Cerebellar 
sections from control L7-CKO mice at different ages were analyzed by 
immunohistochemistry with anti-calbindin. Note the progressive loss of 
Purkinje cells (a, c, e), their axons in white matter (b, d, f), and increasing 
swelling of the axons traversing the granule layer (arrows). Scale bars= 200μm.
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protein aggregates were also detected in the Purkinje cells and white matter of 
the L7-CKO mice (Figure 3.9, panel e). Together, these results strongly suggest 
that FIP200 plays a crucial role in the homeostasis of Purkinje cells in the 
cerebellum and that neural-specific deletion of FIP200 causes cerebellar 
degeneration and ataxia in a Purkinje cell-autonomous manner in mice.
3.3.3 Deletion of FIP200 leads to deficiency of autophagosome and abnormal 
mitochondria
 To explore potential mechanisms by which deletion of FIP200 leads to 
neurodegeneration, I examined possible increases in apoptosis and 
ubiquitinated protein aggregates in the cerebellum of the mutant mice as 
many neurodegenerative diseases are associated with accumulation of 
ubiquitinated protein aggregates and loss of neurons resulting from apoptosis 
(Lossi and Merighi, 2003; Okouchi et al., 2007; Yuan et al., 2003). Owed to 
many neurodegenerative diseases resulted from the deficiency of protein 
quality control systems (UPS and autophagy), I first examined whether the 
proteasome activity is altered by deletion of FIP200 in the cerebellum, as 
impairment of proteasome functions could also lead to abnormal 
accumulation of ubiquitinated protein aggregates (Tai and Schuman, 2008). 
The caspase-like, chymotryptic and tryptic activities of the 20S proteosomes 
were measured by using Ac-GPLD-AMC (and Z-LLE-AMC), Suc-LLVYAMC, 
and Ac-RLR-AMC (and Boc-LRR-AMC) peptides, respectively, as substrates. I 
found that both the caspase-like and chymotryptic activities were elevated in 
the cerebella of Nestin-CKO mice compared to that from control mice at P14 
and P28 (Figure 3.6). The tryptic activity was comparable for the mutant and 
control mice. The increased caspase-like and chymotryptic activities could be
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Figure 3.6 | Proteasome catalytic activity in cerebellum of Nestin-CKO 
mice. Lysates prepared from cerebellum of control or Nestin-CKO mice at P14 
or P28 were measured for their proteasome activities using various substrates 
as indicated. Note that all data were normalized to controls as 100%. The mean 
± s.e. from two independent experiments is shown.
resulting from some feedback mechanism for the cells to attempt to degrade 
the excess accumulation of the ubiquitinated protein aggregates. Together, 
these results suggested that the abnormal accumulation of ubiquitinated 
protein aggregates was likely a consequence of defective autophagy, but not 
decreased proteosome activity, in the CNS of mutant mice.
 Recent studies have shown that basal autophagy is another important 
mechanism to remove abnormal protein aggregates (Hara et al., 2006; 
Komatsu et al., 2006). Suppression of basal autophagy by conditional KO of 
Atg5 or Atg7 in neuronal cells led to abnormal accumulation of ubiquitinated 
protein aggregates and increased apoptosis resulting in neurodegeneration in 
the mutant mice (Hara et al., 2006; Komatsu et al., 2006). Interestingly, FIP200 
has been found recently to interact with ULK1 and 2, the mammalian 
orthologs of yeast Atg1, and the interaction is required for autophagosome 
formation in MEFs (Hara et al., 2008). To investigate potential deficiency in 
autophagosome formation that might account for the abnormal accumulation 
of ubiquitinated protein aggregates upon FIP200 deletion in vivo, I examined 
Purkinje cells in the cerebellum of Nestin-CKO and control mice by 
transmission electron microscopy. As shown in Figure 3.7, multiple 
autophagosomes characterized by the double membrane structures were 
identified in Purkinje cells from control mice (panels a and c, bracketed), but 
none were detected in those from Nestin-CKO (panels b and d). Furthermore, 
in contrast to the smooth and extended morphology of mitochondria in 
control Purkinje cells (panel c, arrows), mitochondria in the mutant Purkinje 
cells were smaller with a more condensed contents and sometimes fragmented 
morphology (panel d, arrows). These results suggested that defective 
autophagy upon deletion of FIP200 may be responsible for the accumulation
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Figure 3.7 | Transmission electron microscopy of the Purkinje cells in 
Nestin-CKO mice. Purkinje cells from control (a, c) and Nestin-CKO (b, d) 
mice at 4 weeks of age were examined by transmission electron microscopy. 
Autophagosomes and mitochondria are marked by dotted rectangles and 
arrows, respectively. Scale bars= 2 μm (a, b) and 500 nm (c, d), respectively.
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of ubiquitinated protein aggregates. Particularly, the accumulation of 
ubiquitinated protein aggregates in the Purkinje cells could be responsible for 
the loss of these cells and their axonal degeneration leading to cerebellar 
ataxia phenotype in the Nestin-CKO mice. Besides, the presence of abnormal 
mitochondria in the mutant cells could be a direct consequence of FIP200 
deletion and owed to the deficiency in autophagy to remove the damaged 
mitochondria efficiently.
3.3.4 Deletion of FIP200 mediated loss of the Purkinje cells and spongiform 
degeneration is through TNFR-1 pathway
 The above analysis raised the possibility that autophagy defects in 
Purkinje cells could lead to increased apoptosis resulting in the loss of 
Purkinje cells and spongiform degeneration upon FIP200 deletion. Yet, the 
increased apoptosis in the cerebellum of Nestin-Cre mice was primarily 
granule cells and other neurons in the white matter rather than Purkinje cells 
per se (Hara et al., 2006; Komatsu et al., 2006). Indeed, I could not detect any 
apoptotic Purkinje cells by TUNEL assay (data not shown) in L7-CKO mice 
despite evident progressive loss of these cells. Interestingly, a previous study 
suggested that the P75 neurotrophic receptor induces autophagy and Purkinje 
cell death (Florez-McClure et al., 2004). To assess the molecular mechanism of 
loss of Purkinje cells and spongiform degeneration upon FIP200 deletion in 
vivo, I introduced floxed p53 allele into L7-CKO mice and generated FIP200flox/
flox;p53flox/flox;L7-Cre double conditional KO mice because up-regulation of p53 
has been indicated as a major mechanism for increased apoptosis in neuronal 
cells (Anderson and Tolkovsky, 1999; Jordan et al., 1997; Martin et al., 2005; 
Martin and Liu, 2002; Wong et al., 2005; Wood and Youle, 1995). Comparison 
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of the cerebellum sections of these mice and L7-CKO mice by calbindin 
staining showed similar extent of Purkinje cell loss (Figure 3.8, panels a and b). 
Furthermore, inactivation of p53 did not rescue spongiform degeneration 
(Figure 3.8, panel c) or accumulation of ubiquitinated protein aggregates (data 
not shown) in L7-CKO mice either. Together, these results suggest that 
Purkinje cell death upon FIP200 deletion is not through p53-mediated 
apoptosis.
 Depletion of FIP200 has been shown to increase apoptosis in the 
embryonic heart and liver and analysis using MEFs and hepatocytes from 
FIP200 KO embryos suggested that increased sensitivity to TNFα-induced 
apoptosis may be responsible for the defective phenotype observed in FIP200 
KO embryos (Gan et al., 2006). TNFα is expressed at a low level in the 
developing brain, which is required for the preservation of synaptic strength 
(Beattie et al., 2002; Dziegielewska et al., 2000; Munoz-Fernandez and Fresno, 
1998). However, increased level of TNFα in neuronal disorders has been 
shown to cause damage to various neurons (Barone et al., 1997; Dawson et al., 
1996). Therefore, it is possible that deletion of FIP200 in Purkinje cells will 
increase their sensitivity to TNFα (similar to MEFs), leading to decreased 
survival. To test such a possibility directly, L7-CKO mice were crossed with 
TNFR-1 KO mice to generate FIP200flox/flox;L7-Cre;TNFR-1-/- double KO mice 
(designated TNFR1dL7-CKO). TNFR-1 is the major receptor for TNFα, and 
although they have some defects in the immune system, TNFR-1 KO mice do 
not exhibit any neurological disorders (Rothe et al., 1993). Figure 3.9 shows 
that deletion of TNFR-1 significantly reduced the Purkinje cell loss (compare 
panels a and b) eliminated spongiform degeneration (compare panels c and d) 
in cerebellum of L7-CKO mice. However, accumulation of ubiquitinated
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Figure 3.8 | Analysis of the Purkinje cells and spongiform degeneration in 
FIP200flox/flox;P53flox/flox;L7-Cre mice. Cerebellum sections from L7-CKO (a) or 
FIP200flox/flox;p53flox/flox;L7-Cre (b, c) at 16 weeks were analyzed by 
immunohistochemistry with anti-calbindin (a, b) or staining with H/E (c). 
Scale bars=200 μm.
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Figure 3.9 | Analysis of the Purkinje cells and spongiform degeneration in 
FIP200flox/flox;L7-Cre;TNFR-1-/- mice. Cerebellum sections from L7-CKO (a, c, e) 
or FIP200flox/flox;L7-Cre;TNFR-1-/- (TNFR-1dL7-CKO)(b, d, f) at 8 weeks were 
analyzed by immunohistochemistry with anti-calbindin (a, b), anti-ubiquitin 
(e, f) or staining with H/E (c, d). Scale bars=200 μm.
162
protein aggregates remained existing in both transgenic mice (see panels e and 
f). 
 In addition, it has been known that activation of TNFR-1 can trigger cell 
death by releasing cytochrome c from mitochondria (Guicciardi et al., 2000; 
Kim and Kim, 2003; Mabrouk et al., 2007). As shown in Figure 3.7, deletion of 
FIP200 led to an accumulation of abnormal mitochondria in the Purkinje cells. 
Figure 3.9 (compare panel a and b) also indicated that the depletion of TNFR-1 
reduced loss of the Purkinje cells. Hence, an increased sensitivity to cell death 
in FIP200-depleted Purkinje cells may be resulting from TNFR-1-mediated 
cytochrome c release. To test the possibility, I next examined the Purkinje cells 
in L7-CKO and TNFR-1dL7-CKO by staining of the cerebellar sections with 
anti-cytochrome c (Figure 3.10). Interestingly, I found that a notable 
cytochrome c release in the Purkinje cells of L7-CKO mice (compare panel a 
and b). The cytochrome c release in the Purkinje cells of L7-CKO was 
significantly reduced by inactivation of TNFR-1. (compare panel b and c) 
Lastly, I found that TNFR-1 KO partially restored the motor coordination of 
L7-CKO mice as measured by Rota-Rod tests (Figure 3.11). These results 
suggest that increased sensitivity to TNFα-induced cell death may at least 
partly account for Purkinje cell loss and associated spongiform degeneration 
upon deletion of FIP200.
3.4 Discussion
 Purkinje cells are the master neurons of the cerebellar cortex and are the 
only efferent   relay to the central nervous system through their axon 
connections to the deep cerebellar nuclei. These cells are born during
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Figure 3.10 | Inactivation of TNFR1 reduce cytochrome c release in the 
Purkinje cells of L7-CKO. Cerebellum sections from control, L7-CKO or 
TNFR-1dL7-CKO at 8 weeks were analyzed by immunohistochemistry with 
anti-cytochrome c. Scale bars=50 μm.
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Figure 3.11 | Movement ataxia in TNFR1dL7-CKO mice. Control, L7-CKO or 
TNFR1dL7-CKO (n=3) mice at different ages were placed on accelerating 
rotarods and latency to fall were recorded. Note that data were normalized to 
control. The mean ± s.e. are shown.
embryogenesis (Leclerc et al., 1988; Oberdick et al., 1993; Seil et al., 1995; 
Wassef et al., 1990) and form a monolayer separating the  molecular and the 
internal granule layers by the first 2-3 postnatal weeks (Altman, 1972a; 
Altman, 1972b; Goldowitz and Hamre, 1998). My studies using three different 
Cre lines with complementary patterns of Cre expression in the 
cerebellum provided strong support for a Purkinje cell-autonomous function 
of FIP200 in the homeostasis of   these cells and cerebellar ataxia upon its 
inactivation. Mice with deletion of FIP200 mediated by nestin-Cre or L7-Cre 
both developed cerebellar ataxia within a few weeks of age. Deletion of FIP200 
mediated by hGFAP-Cre, which does not express Cre in Purkinje cells, did not 
show any   neurological disorders within the same time-frame. The later 
appearance of ataxia also correlated   to the loss of Purkinje in these mice, 
which likely results from the deficiency in granule cells or other neurons in the 
cerebellum.  My studies identified a function for FIP200 in the regulation of 
neuronal cell homeostasis and its inactivation caused cerebellar degeneration 
and ataxia accompanied with   progressive accumulation of abnormal 
ubiquitinated protein aggregates, loss of Purkinje cells,  axonal swelling and 
spongiform degeneration.
 Protein quality control mechanisms including the UPS and autophagy 
have been suggested to play crucial roles in the homeostasis of neurons and in 
neurodegeneration (Berke and Paulson, 2003; Ciechanover, 2006; Mizushima 
and Klionsky, 2007; Pickart, 2004; Rubinsztein, 2006). Nevertheless, the 
molecular components and signaling pathways that regulate these cellular 
processes in various neurodegenerative diseases are still not well understood 
at present.   Deletion of FIP200 resulted in neurological defects that share 
several characteristics with the recently reported Atg5 or Atg7 conditional KO 
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mice by nestin-Cre (Hara et al., 2006; Komatsu et al., 2006), including the 
increased ubiquitin aggregates without any deficiency in proteasome catalytic 
functions. Interestingly, a recent study identified an interaction between 
FIP200 and ULK1, the mammalian homolog of yeast Atg1, and showed that 
FIP200 is required for starvation-induced autophagy in mammalian cells   in 
vitro (Hara et al., 2008). Thus, the data presented here strongly suggest a role 
of FIP200 in the regulation of autophagy in vivo and deficiency in autophagy 
upon FIP200 inactivation is likely a major contributor to neurodegeneration in 
the mutant mice. The contents of the abnormally accumulated ubiquitinated 
protein aggregates in the FIP200 conditional KO mice, nor those in the Atg5 or 
Atg7 conditional KO  mice are unknown. However, it is conceivable that 
different protein aggregates were accumulated in the FIP200 conditional KO 
mice vs Atg5 or Atg7 conditional KO mouse, which may account for 
the  differential phenotype in FIP200 conditional KO mice. In some cases of 
neurodegenerative mice KO   models, the responsible protein aggregates 
contributing to the neuronal swelling and neurodegeneration are known, such 
as Prion in TSE (Hooper, 2003) and TDP-43 in Sod1-/- (Arai et al., 2006; 
Neumann et al., 2006). Future studies will  be directed at identifying the 
proteins in the ubiquitinated aggregates of FIP200 conditional KO mice and 
determining whether any of these are responsible for the axonal swelling, 
spongiform degeneration, and other cerebellar degenerative phenotypes.
 My studies also characterized several distinctive neurological features of 
neural-specific FIP200 conditional KO mice including the progressive 
development of spongiform degeneration that were not observed in the Atg5 
or Atg7 conditional KO mice (Hara et al., 2006; Komatsu et al., 2006) and 
indeed rarely found in other KO mice models (Akassoglou et al., 2004; Li et al., 
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1995; Lin et al., 2004; Matalon et al., 2000; Puccio et al., 2001). Mitochondrial 
damage was also observed in FIP200 conditional KO mice, but not reported 
for Atg5 or Atg7 KO mice. FIP200 has been shown to regulate several other 
signaling pathways and cellular processes besides its interaction with ULK1 
and regulation of autophagy (Hara et al., 2008). It is therefore possible that 
perturbations of other signaling pathways may contribute to these distinct 
phenotypes in the FIP200 conditional KO mice.
 While my data excluded a role of p53-dependent apoptosis, I found that 
deletion of TNFR-1 rescued both the loss of Purkinje cells and spongiform 
degeneration in FIP200 conditional KO mice, suggesting that altered 
TNFα signaling may play a crucial role in cerebellar degeneration upon FIP200 
deletion. Increased TNFα  production from microglia associated with pro-
inflammatory responses have been found in brain injury and 
neurodegeneration such as Alzheimer’s (Bruunsgaard et al., 1999; Collins et 
al., 2000) and Parkinson’s diseases (Boka et al., 1994; Dobbs et al., 1999; Mogi 
et al., 1994; Nishimura et al., 2001). However, I did not detect any signs of 
inflammation in the cerebellum of FIP200 conditional KO mice (data not 
shown). Thus, it is possible, or even likely, that deletion of FIP200 resulted in 
an increased sensitivity of Purkinje cells to TNFα-induced cell death, similar to 
our previous findings in FIP200 KO MEFs (Gan et al., 2006). It is also 
interesting to note that TNFR-1 deficiency only partially reduced 
accumulation of ubiquitinated protein aggregates, suggesting that altered 
TNFR-1 signaling is distinct from the autophagy defects caused by FIP200 
inactivation. On the other hand, I also observed increased cytochrome c 
release in the Purkinje cells of L7-CKO was rescued by TNFR-1 deficiency. The 
observation suggests that TNFα signaling may play a crucial role in
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Figure 3.12 | Role of FIP200 in neurodegeneration.
mitochondrial damage independent of defective autophagy in these neurons 
while both could contribute to the loss of Purkinje cells and spongiform 
degeneration leading to cerebellar ataxia.
 In summary, these results identified that FIP200 as a novel regulator of 
neuronal homeostasis and provide novel insight into molecular and cellular 
mechanisms of pathogenesis of neurodegenerative diseases as summarized in 
a working model (Figure 3.12). The set of   FIP200 conditional KO mice may 
provide useful mice models for future studies on the mechanisms of cerebellar 
degeneration and ataxia as well as promising therapeutic approaches for the 
diseases in humans.
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CHAPTER 4
CONCLUSIONS AND PROSPECTS
4.1 Conclusions
 FIP200 has been shown to play a role in various cellular functions via 
regulating numerous signaling pathways. My study emphasized the critical 
role of FIP200 in neuronal homeostasis and survival. Ablation of FIP200 in the 
neural progenitor cells led to several typical neurophathies, including 
accumulation of polyubiquitin-containing protein aggregates, progressive 
axonopathy and spongiform degeneration, as well as increased neuronal cell 
death. These cellular defects resulted in growth retardation, development of 
ataxia and paralysis, as well as early death in FIP200 mutant mice. Studies 
using mice with FIP200 deletion in the Purkinje cell only demonstrated the 
Purkinje cell autonomous function of FIP200 in the regulation of cerebellar 
degeneration and ataxia. At the molecular level, the study also addressed the 
importance of FIP200 in autophagy, particularly the autophagosome formation 
in CNS. Owed to the intact function of the UPS and the deficiency in 
autophagosome formation that I found in previous chapters, the results 
suggested that the deficiency of autophagosome formation is responsible for 
the accumulation of abnormal protein aggregates in FIP200 mutant mice. 
Additionally, unhealthy and fragmented mitochondria were found in the 
Purkinje cells, suggesting that FIP200 is likely involved in mitochondrial 
fusion and fission machinery to maintain the intact function of mitochondria. 
The dysfunctional mitochondria may further produce increase cellular levels 
of ROS to damage the other cellular machineries. More interestingly, the 
inactivation of TNFR-1 in L7-CKO transgenic mice resulted in a significant 
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improvement in the Purkinje cell survival and removal of spongiform 
degeneration. However, the inactivation of TNFR-1 in L7-CKO mutant mice is 
unable to prevent the Purkinje cells from the formation of protein aggregates 
and axonal swelling. The results indicated that the death of Purkinje cells and 
the spongiform degeneration are tightly correlated with the TNF-R1-FIP200 
pathway. In contrast, the transgenic mice with the specific deletion of both 
FIP200 and p53 in the Purkinje cells still showed protein aggregates, loss of the 
Purkinje cells, spongiform degeneration, and ataxia. The data suggested that 
the loss of the Purkinje cells is not via a p53-dependent mechanism in FIP200 
L7-CKO mice.
4.2 Future Prospects 
4.2.1 UPS, autophagy, and protein aggregates
 Among various phenotypes found in the FIP200 mutant mice, 
polyubiquitin aggregates is the key feature that leads to neurodegeneration. It 
is well known that both the UPS and autophagy are the major cellular protein 
quality control systems. The deficiency in the UPS or autophagy causes 
aberrant protein accumulation within the cells. The protein aggregates could 
be either neurotoxic to cells or neuroprotective to remove the soluble toxic 
proteins in the cytoplasm. The results amassed from our FIP200 mutant mice 
clearly showed that protein aggregates generated is because of the deficiency 
of autophagosome formation but not the altered proteasome catalytic activity. 
Recent studies have shown that FIP200 forms a functional protein complex 
with ULKs and Atg13 to initiate autophagosome formation (Hara et al., 
2008). This evidence suggests that the protein aggregates found in the FIP200 
mutant mice are likely resulting from the defects in the ULK1-Atg13-FIP200 
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protein complex.  However,   it remains ambiguous what is the role of the 
ULK1-Atg13-FIP200 protein complex is in vivo, particularly in CNS. Therefore, 
it will be interesting to study whether the ULK1-Atg13-FIP200 protein 
complex is involved in neural development, differentiation, and synapse 
formation by analyzing ULK1-null mice (Kundu et al., 2008) and Atg13-null 
transgenic mice (if available).
 Another question for the ULK1-Atg13-FIP200 protein complex is the 
potential different physiological consequences between the deficiency of 
autophagosome initiation caused by deletion of FIP200 (or ULK1, Atg13) and 
Atg5/7 null-mediated autophagy defects. Recent reports have revealed that 
the conditional KO of Atg5 or Atg7 in CNS led to the aggregation of 
polyubiquitinated proteins resulting neurodegeneration (Hara et al., 2006; 
Komatsu et al., 2006). The results collected from Atg7-null transgenic mice 
suggest that the death of the Purkinje cell is via apoptosis. In contrast, the loss 
of the Purkinje cells in FIP200 mutant mice is TUNEL negative, and, 
furthermore, it is independent of p53-mediate apoptosis. These observations 
also make it interesting to investigate the causes for the loss of the Purkinje 
cells in FIP200 mutant mice. As mentioned in the introduction, the aggregation 
of polyubiquitin-containing proteins leads to loss of their normal functions 
that could lead to cell death.   If the death of the Purkinje cells is owed to 
protein aggregates, the content of the aggregates could be different between 
FIP200 CKO and Atg5/7 CKO mice. It is possible to identify the contents in 
the protein aggregates like the case that the scientists finally targeted TDP-43 
is the major aggregated protein in the inclusion bodies of ALS patients 
(Neumann et al., 2006). Therefore, identification of the contents in protein 
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aggregates from FIP200 mutant mice may reveal the role of ULK1-Atg13-
FIP200 functions in vivo. 
 Although my data suggest that the protein aggregates is not caused by 
impaired proteasome catalytic activity in FIP200 CKO mice, it is still possible 
that FIP200 could regulate the UPS by functioning as a proteasomal targeting 
protein. A recent study has revealed that a group of proteins, such as UFD2, 
RAD23, DSK2 and RPN10, escort the ubiquitinated proteins to proteasome for 
ultimate degradation (Richly et al., 2005). Preliminary data from others in our 
lab showed that FIP200 can associate with both ubiquitin and several subunits 
of 19s proteasome. Therefore, it is also interesting to study whether FIP200 is 
an ubiquitin binding protein to transfer ubiquitinylated substrates to 
proteasome.
4.2.1 Mitochondria, ROS and spongiform degeneration
 Spongiform degeneration is a rare neuropathic feature. It has been 
proposed that dysfunctional  proteasome and altered ubiquitination process 
may contribute to the phenotype. However, the results collected from 
proteasome catalytic activities analysis showed that 20S proteasome subunits 
had slightly increased catalytic activities in FIP200 CKO mice. Therefore, the 
malfunction of the UPS is not the case to cause spongiform degeneration in the 
FIP200 mutant mice.   Indeed, the accumulation of polyubiquitin-containing 
protein can affect a number of cellular pathways by increasing cellular stress. 
According to a recent report, when the cell is exposed to mild oxidative stress 
(Zeevalk and Bernard, 2005) it is often found to exhibit the 
elevated   proteasome activity. The increase in catalytic activity of the 
proteasome was proposed to be the response to facilitate the removal of 
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protein substrates. One major source of cellular stress is the ROS (Berlett and 
Stadtman, 1997; Klein and Ackerman, 2003). ROS are primarily produced from 
the mitochondrial electron transport chain (ETC). The ETC has been identified 
as one of the cellular generators of ROS, including superoxide (O2-), hydrogen 
peroxide (H2O2) and the hydroxyl free radical (·OH) (Boveris et al., 1972; 
Chance et al., 1979; Loschen et al., 1971). The cellular level of ROS is also 
controlled by cellular antioxidant systems (Barrientos and Moraes, 1999; Chen 
et al., 2003; Nicholls, 2002; Nohl et al., 2003).
 Although low levels of ROS can function as an intracellular signal (Aslan 
and Ozben, 2003; Finkel, 2001), high levels of ROS change protein 
conformation, alter enzyme activity including proteasome (Carrard et al., 
2002), and increase abnormal ubiquitinated protein aggregation (Adamo et al., 
1999; Ardley et al., 2004; Biasini et al., 2004; Rideout et al., 2001; Rideout and 
Stefanis, 2002).   Furthermore, the impaired mitochondria can lead to an 
increase of ROS and release of mitochondrial components into the cytoplasm, 
which trigger cell death (Chinopoulos and Adam-Vizi, 2001; Chinopoulos et 
al., 1999; Zhang et al., 2001). The mitochondria-mediated cell death can be 
intrinsic or extrinsic (Donovan and Cotter, 2004; Li et al., 2004; Marshansky et 
al., 2001; Peruzzi et al., 2001). Interestingly, recent studies indicate that a cross-
talk mechanism between the UPS and mitochondria plays a role in maintain 
both system activities (Carrard et al., 2002; Ding and Keller, 2001; Li et al., 
2003; Papa et al., 2007; Rinaldi et al., 2004; Shamoto-Nagai et al., 2003; Sullivan 
et al., 2004; Zeevalk and Bernard, 2005)  as well as in  cell death (Papa and 
Rockwell, 2008). The UPS may be also crucial for the   the maintenance 
of mitochondrial function and health by regulating the mitochondrial fusion 
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and fission machinery (Altmann and Westermann, 2005; Durr et al., 2006; Fritz 
et al., 2003; Nakamura and Hirose, 2008; Nakamura et al., 2006).
 The TEM results amassed from the Purkinje cells of Nestin-CKO mice 
showed that abnormal fragmented mitochondria and the IHC data gathered 
from L7-CKO exhibited an increase of cytochrome c in the Purkinje cells. The 
data suggested that the function of mitochondria may be regulated by 
FIP200. Although it remains unclear how FIP200 involves in the mitochondrial 
machinery, the studies from two knockout models,  manganese superoxide 
dismutase (Sod2) and     NF-E2-related factor (Nrf2)   in oxidative stress 
signaling,   associated with mitochondrial dysfunction and spongiform 
degeneration (Hubbs et al., 2007; Melov et al., 1998; Pederzolli et al., 2007; 
Zhang et al., 2001). The results suggest the important role of ROS regulation in 
the brain. In addition, mutation of   ETC complex IV subunit VIa causes 
deficiency   in mitochondrial function, leading to spongiform change in fruit 
flies (Liu et al., 2007). These results indicate that malfunction of mitochondria 
and an increase of ROS can cause vacuolization and cell death in the 
brain.  Therefore, it will be interesting to study the role of FIP200 in several 
mitochondrial functions, including ETC, fusion and fission machinery, as well 
as cellular antioxidant systems.
 In addition, studies have shown that oxidative-stress-induced 
spongiform pathology can be reduced by the treatment of antioxidants (Gomi 
et al., 1994; Hinerfeld et al., 2004; Jiang et al., 2006; Pederzolli et al., 2007). The 
antioxidant treatment decreases cell death in   Zitter   rats (Gomi et al., 
1994),  SOD2−/−  mice (Hinerfeld et al., 2004), and cells exposed to N-acetyl-l-
aspartate (NAA) (Pederzolli et al., 2007). High levels of ROS can also promote 
protein aggregation (Carrard et al., 2002; Dear et al., 2007; Ross and Poirier, 
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2004; Shamoto-Nagai et al., 2003) and trigger apoptosis signaling in neurons, 
resulting in spongiform degeneration and massive cell death. Similar to Prion 
functioning as a potential antioxidant by binding copper, FIP200 could play a 
role in the regulation of ROS. 
4.2.3 TNFR-1-FIP200 pathway in neurogenesis and neurodegeneration
 The most intriguing finding in my study is that loss of the Purkinje cells, 
spongiform degeneration, and incoordinated movement of L7-CKO mice were 
significantly rescued by inaction of TNFR-1. Moreover, cytochrome c release in 
L7-CKO mice was also reduced upon inactivation of TNFR-1. These data 
strongly suggest that altered TNF-R1 pathway is responsible for the 
neurophathic features found in L7-CKO cerebellum. As mentioned in the last 
section, release of cytochrome c is resulting from dysfunctional mitochondria 
under oxidative stress. Hence, it will be interesting to study the mechanism by 
which TNFR-1-FIP200 pathway regulates cell survival in cerebellum.
 Neurotrophic factors play an important role in many cellular functions of 
neurons, including cell survival (Hempstead, 2006), axon outgrowth and 
guidance (Reichardt, 2006), and cell growth (Allen and Dawbarn, 2006). A 
recent study has revealed that DR6, a TNF superfamily members, triggers 
neurodegeneration through different caspases (Nikolaev et al., 2009). The 
result implies that the activation TNFR-1 may also regulate neuronal survival. 
For example, in the normal Purkinje cells, the activation of TNFR-1 can recruit 
FIP200, resulting in phosphorylation of JNK and cell survival. However, in the 
L7-CKO mice, the activation of TNFR-1 may initiate apoptosis via caspases 
cascade.
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 Numerous studies have shown that TNFα is the primary factor of 
immune response in CNS (Nguyen et al., 2002; Turrin and Rivest, 2006). TNFα 
regulates various cellular effects by activating two distinct receptors, TNFR-1 
mainly for neuronal death and TNF-R2 for neuroprotection (Bernardino et al., 
2005; Fontaine et al., 2002; Marchetti et al., 2004; Yang et al., 2002). It has been 
shown that both neural stem cell (NSC) and progenitor cells express TNFα 
(Iosif et al., 2006; Klassen et al., 2003) as well as the receptors (Ben-Hur et al., 
2003; Cacci et al., 2005; Iosif et al., 2006; Sheng et al., 2005; Widera et al., 2006). 
Several recent studies emphasize the essential role of TNFα in neurogenesis. 
For example, an increase in proliferation is found at the subventricular zone in 
the TNFα-treated rats (Wu et al., 2000) and in vivo infusion of a neutralizing 
antibody against TNFα reduce the number of neuroblasts in striatum and 
hippocampus (Heldmann et al., 2005). Interestingly, a study using TNFα 
receptors null mice has demonstrated that in neural progenitor cells TNFR-1 
acts as a suppressor for proliferation but TNFR-2 functions as a promotor for 
their survival (Iosif et al., 2006). Nuclear factor B and cyclin D1 have been 
shown to regulate the TNFα-induced proliferation of NSCs in vitro (Widera et 
al., 2006). Furthermore, the TNFα-activated SAPK/JNK signaling pathway is 
also important in regulation of neuronal cell proliferation and death 
(Bernardino et al., 2008). Taken collectively, the recent results suggest an 
essential role of TNFα in neurogenesis.
 Although the preliminary results are not included in the study, TNFR-1 
null mice with FIP200 deletion in neural progenitor cells (FIP200flox/flox, 
TNFR-1-/-; nestin-Cre) were born in Mendelian ratio but died within 72 hr, 
which is even earlier than CKO mice. I found that FIP200flox/flox, TNFR-1-/-; 
nestin-Cre mouse showed increased apoptosis in the cerebellum and 
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hippocampus where neurogenesis occurs compared to CKO mice. The results 
suggest that TNFR-1-FIP200 pathway may be critical for CNS development. It 
will be interesting to investigate the synergistic effect of TNFR-1 and FIP200 
on neurogenesis and neurodegeneration. The results will reveal the 
importance of TNF-R1-FIP200 pathway in both mitotic and post-mitotic 
neurons. In addition, TNFR-2 expresses in the NSCs and its downstream 
molecules, like TRAF-2, can interact with FIP200. It will be interesting to 
investigate the mechanism by which FIP200 regulates NSC survival and 
proliferation through TNFR-2. 
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